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Rapid Progressive Dementia with Probable Sporadic Creutzfeldt-Jakob Disease 
Sinan Khayyat, M.D., Daly Al-Hadeethi, M.D., Mohinder Vindyhal, M.D., M.Ed. 
KU School of Medicine-Wichita 
[Judges Award: Best Poster] 
 
Introduction 
Prion diseases are rare neurodegenerative diseases which usually have long incubation 
periods and rapidly worsening neurological outcomes. Creutzfeldt-Jakob Disease (CJD) is a rare 
human prion disease with progressive, fatal encephalopathy characterized by dementia, 
cerebellar ataxia, and visual disturbances. CJD is caused by an abnormal protease-resistant 
isoform of prion protein (PrPSc), a misfolded version of the normal cellular isoform (PrPC). It is 
a rare disease with an incidence rate of approximately one case per million population per year 
with a worldwide distribution. We present an elderly male with Creutzfeldt-Jakob Disease 
(CJD). 
 
Case Description 
An 85-year-old man presented with confusion, aphasia, and episodic seizure-like activity in 
his right upper extremity and right eye twitching for two weeks duration. Neurological exam 
revealed stupor, aphasia, verbal non-responsiveness, generalized weakness, and lower extremity 
myoclonic movements. Pupils were constricted but reactive to light with no facial asymmetry. 
Cogwheel rigidity was noticed with only equivocal left Babinski. Workup for confusion showed 
generalized cerebral atrophy and chronic microvascular changes with scattered focal and 
confluent areas of nonspecific T2 bright signal in the periventricular and subcortical white matter 
but no acute events on MRI. EEG showed diffuse slowing with transient generalized 
epileptiform discharges for which the patient was started on anti-seizure medication. Lumbar 
puncture ruled out meningitis/encephalitis. CSF studies were negative for infectious and parasitic 
etiology. The CSF studies were also sent for 14-3-3 antigen test, which was elevated. Tau protein 
level was >4000 and Real-Time Quaking-Induced Conversion assay was also positive. The 
clinical diagnosis of CJD was given. The patient was discharged to hospice and passed away 
soon after that. 
 
Conclusions 
The definitive diagnosis of CJD is made with a brain tissue biopsy and western blot 
confirmation of protease-resistant PrP and presence of scrapie-associated fibrils. Criteria for the 
diagnosis of probable sporadic CJD in patients presenting with rapid progressive dementia are 
two of the following: myoclonus, visual or cerebellar signs, pyramidal/extrapyramidal signs, 
akinetic mutism, and a positive result of either a typical EEG with periodic sharp wave 
complexes and/or a positive 14-3-3 cerebrospinal fluid (CSF) assay. Our patient met criteria of 
probable sporadic CJD with the presence of progressive dementia, akinetic mutism, myoclonus, 
and an extrapyramidal sign of rigidity with positive 14-3-3 CSF assay. Our patient also tested 
positive on the Real Time Quaking-Induced Conversion assay which has high sensitivity and 
specificity for CJD disease. Prognosis with CJD has a rapid, deteriorating course invariably, with 
death generally within two years of symptom onset. No treatment has been proposed so far, and 
few medications help with symptoms. Early diagnosis also allows patients and their families to 
prepare for the expected disease course. 
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When it isn’t Sepsis: A Case Report of Hemophagocytic Lymphohistiocytosis 
Kelsy Witherspoon, M.D., Mohinder R. Vindhyal, M.D., M.Ed. 
KU School of Medicine-Wichita 
[Chien Liu Award for Best Infectious Disease Poster] 
 
Introduction 
Hemophagocytic lymphohistiocytosis (HLH), a rare syndrome of immune dysregulation, can 
lead to clinical signs and symptoms of severe systemic inflammation, often mimicking more 
common presentations of illnesses. While primary HLH is an inherited disorder seen in 
childhood, secondary HLH presents in adults and results from infections, connective tissue 
disorders, or malignancies. HLH has a high mortality rate without rapid identification and 
intervention. Here, we present a case of secondary HLH in an elderly African-American male 
patient.  
 
Case Presentation 
A 69-year-old African-American man with a history of insulin-dependent diabetes, coronary 
artery disease, hypertension, chronic iron deficiency anemia, chronic heart failure, untreated 
Hepatitis C, and compensated cirrhosis presented with a three-month history of non-specific 
right upper quadrant and epigastric abdominal pain with diarrhea and a 20-pound weight loss. 
Admission labs were notable for leukopenia (3.0 K/cmm) and elevated lipase (1096; standard 
range 73-393 units). CT Abdomen/Pelvis showed non-specific findings of fluid and air-filled 
colon, suggestive of possible enteritis. GI Panel was negative for infectious diarrheal causes. The 
patient was soon discharged after being provided supportive care for suspected pancreatitis and 
viral enteritis. The patient returned after a week with acute onset high fevers (38.3 C - 39.4 C). 
Admission labs during the repeated admission showed pancytopenia with Hgb at 7.9 g/dL, a 
platelet count of 140 K/cmm, and severe neutropenia (ANC 322). Additional workup revealed 
the presence of hemophagocytosis with pancytopenia on peripheral smear and bone marrow 
biopsy. Follow-up labs also showed elevated ferritin of 13,869 ug/L and low fibrinogen 1.19 g/L 
in the face of persistent fevers (> 38.50 C). He was diagnosed with HLH based on the criteria 
and started on high dose dexamethasone and etoposide by Oncology. 
 
Conclusions 
A definitive diagnosis of HLH remains challenging, largely due to its variable clinical 
presentations and relative infrequency. The diagnosis is often delayed or mistaken for other 
etiologies. HLH can be diagnosed when patients have a gene mutation consistent with familial 
HLH or have at least five out of eight diagnostic criteria, as was the case with this patient.  
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Not Nearly Enough Kleenex: A Life Threatening Vascular Tumor Complication 
Ryan Morse, Jesse Richards, D.O., Matthew Swan, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Kasabach-Merritt syndrome (KMS) is a rare disease that occurs when a vascular tumor 
causes a consumptive coagulopathy. The tumor traps platelets and clotting factors, leading to 
thrombocytopenia and a high risk of bleeding that may prove to be fatal. The rarity of this 
disorder creates a difficult clinical diagnosis, occurring in approximately 0.3% of hemangiomas. 
 
Case Presentation 
A 42-year-old female with a malignant hemangioendothelioma presented as a transfer with 
an uncontrolled nosebleed for the past five hours. The patient reported waking that morning from 
her sleep drenched in her own blood. EMS took her to the local hospital where her Hgb was 
recorded 5.7, platelets were 6,000, and a normal INR and fibrinogen. After bilateral nasal 
packing followed with multiple units of packed RBCs and platelets, hemostasis was unsuccessful 
and transfer to a tertiary institution was initiated. Upon arrival, she was seen by ENT and noted 
to be in severe distress with a 400-mL emesis of frank blood. Nares were packed bilaterally and 
large clots were observed on oral exam with blood running down the posterior oropharynx. 
Fluids, RBCs, cryoprecipitate, and platelets were given in an attempt to achieve hemostasis. 
Previous nasal packing was removed and replaced, without cessation of bleeding, thus insertion 
of an inflatable nasal balloon catheter was attempted next. The patient continued to bleed 
profusely with recurrent hemoptysis. An immediate rapid response was called and the patient 
was transferred to the ICU, where she was promptly intubated for airway protection. 
With multiple failed packing attempts to cease bleeding, the patient was taken emergently to 
interventional radiology. Angiogram was performed with embolization of bilateral 
sphenopalatine arteries and control of bleeding was finally achieved. Imaging highlighted 
significant vascular tumor metastases in the posterior pharynx and skull base. With arterial 
embolization, the patient stabilized and was extubated a few days later. Nasal packing was 
removed and with the cessation of bleeding being complete, the patient was discharged.  
 
Conclusions 
A patient in the emergency room with epistaxis is not unusual, however, the differential for 
epistaxis can be quite broad and not always as straightforward as expected. This case highlighted 
a patient with a biopsy-proven malignant hemangioendothelioma, presenting with a rare 
syndrome. KMS occurs when the tumor consumes and actives platelets within blood vessels, 
causing microvasculature thrombosis and bleeding. In addition, the small vessel thrombi shear 
red blood cells and cause end-organ damage. Seen commonly in 60% of the population, 
uncomplicated epistaxis normally resolves with conservative measures. Refractory bleeding 
should heighten clinical suspicion that a common nosebleed could in fact be the presentation of a 
systemic bleeding diathesis. When KMS occurs, patients are at very high risk for bleeding, 
hemorrhagic shock, and death. Prompt evaluation with urgent intervention is life-saving. 
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Sepsis-Induced Radiation Recall Dermatitis  
after Chemotherapy with Irinotecan and Bevacizumab  
John Frey, D.O., Christopher Streiler, M.D., Matthew Swan, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Radiation recall dermatitis (RRD) is an inflammatory reaction that occurs at previously 
irradiated sites. It is a rare phenomenon that typically occurs after the administration of certain 
drugs, days to years after radiation therapy. We report a case of sepsis-induced RRD in a patient 
receiving Irinotecan and Bevacizumab. 
 
Case Presentation 
A 35-year-old female was diagnosed with metastatic rectal adenocarcinoma and was initially 
treated with Capecitabine and concurrent radiation to the abdomen, pelvis, and lower extremities, 
for a total dose of 50.4 Gy. Due to progression of her disease she was treated with FOLFOX and 
Bevacizumab, followed by Capecitabine and Bevacizumab, then Irinotecan and Bevacizumab. 
Seven months after initiating chemotherapy with Irinotecan and Bevacizumab, the patient 
presented to the hospital for a one-day history of fever, headache, back pain, abdominal pain, 
painful rash, and diarrhea following an epidural steroid injection the week before. Vital signs 
were significant for fever and tachycardia. The patient’s exam was remarkable for photophobia, 
tenderness to palpation in the suprapubic region, as well as the thoracic and lumbar spine. 
Furthermore, there were maculopapular erythematous blanching patchy lesions located on the 
anterior aspect of both lower extremities from the hip to knee. Labs were remarkable for 
leukocytosis and lactic acidosis. The patient was admitted for sepsis and empirically started on 
Vancomycin and Piperacillin/Tazobactam. Given her symptoms, there was concern for 
development of spinal abscess and/or meningitis. MRI of the T/L-spine was obtained which was 
negative for spinal abscess. A lumbar puncture was performed with studies suggestive of viral 
meningitis, cultures were negative. In the following days, her blood cultures were positive for 
Streptococcus agalactiae, and her stool sample was positive for Clostridium difficile. Her 
antibiotic regimen was changed to Cefazolin and oral Vancomycin.  
While the patient’s systemic symptoms began to improve with antibiotic administration, the 
erythema on the patient’s legs continued to progress. It ultimately became sharply demarcated, 
and when prompted, the patient stated the erythema was localized to the area of her prior 
radiation treatments. Upon further questioning regarding her history of radiation dermatitis, she 
stated the pain was the exact same as when she received radiation. Given the nature and 
description of the lesions, the patient was diagnosed with RRD. Since she had received 14 cycles 
of Irinotecan and Bevacizumab without complication, and development of the dermatitis 
coincided with onset of her systemic symptoms, her RRD was determined to be secondary to 
sepsis.  
 
Conclusions 
While RRD is typically attributed to the administration of certain drugs, this case provides 
evidence that environmental factors may also trigger RRD. To our knowledge, this is the first 
report of sepsis as a trigger for RRD. Future work is needed to uncover the underlying 
pathophysiology of RRD.  
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Macrophage Recruitment during Liver Repair is Attenuated and Delayed  
by Hyaluronan Synthesis Inhibition 
Ben Harstine, Jennifer M. McCracken, Ph.D., Lei Jiang, Ph.D.,  
Michele T. Pritchard, Ph.D. 
KU School of Medicine-Kansas City 
 
Introduction 
The liver possesses a remarkable capacity to repair following injury. The difference between 
regenerative and non-regenerative wound healing is orchestrated, in part, by the recruitment of 
macrophages (møs) and their sequential development of different wound-repair phenotypes. 
Hyaluronan (HA), an ECM component, is synthesized and degraded during repair of extrahepatic 
tissues. The role of HA in liver repair is unknown. The purpose of this study was to evaluate the 
role of hyaluronan in mø phenotypic change that occurred throughout liver wound repair.  
 
Methods 
Wild type mice fed either a standard diet or a hyaluronan synthesis inhibiting diet containing 
4-methylumbelliferone (4-MU) were given one dose of carbon tetrachloride (CCl4) to cause 
acute liver injury. Markers of injury, regenerative wound healing, mø phenotype, and ECM 
composition were evaluated.  
 
Results 
HA was induced by CCl4-induced liver injury. 4-MU feeding did not alter CCl4-induced 
liver injury or synthesis of the macrophage recruiting chemokine, Ccl2 (MCP1). However, 
injury-induced HA synthesis was inhibited in 4-MU fed mice relative to mice fed the control 
diet. Moreover, hepatocyte proliferation was suppressed 75% in 4-MU fed mice following injury 
and cyclin mRNA transcripts demonstrated a proliferative delay. After acute injury, mø 
recruitment, as assessed using QPCR for macrophage-specific markers, was elevated at 72h and 
120h post-CCl4 in mice fed the control diet, indicating recruitment of peripheral møs. However, 
these same parameters were suppressed in 4-MU fed mice. Furthermore, fibrosis resolution after 
chronic CCl4 was delayed in 4-MU-fed mice.  
 
Conclusions 
HA is a prominent feature of regenerating livers and is crucial for mø recruitment during this 
process. HA is also crucial for promoting normal hepatocyte proliferation following injury, 
perhaps through the recruitment, phenotypic change, and subsequent activity of møs.  
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Once Bitten, Twice Shy: The Thick and Thin of Blood Parasites 
Jamison Ryan, M.D., Lisa Clough, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Malaria is caused by blood parasites of the genus Plasmodium and is transmitted to humans 
by infected mosquitoes. Malaria is rarely seen in the U.S., but due to its severity, it should be 
routinely considered in febrile patients with travel to known endemic regions. Symptoms are 
often non-specific, which means a high degree of clinical suspicion should be maintained, 
particularly in patients with fever of unknown origin and an appropriate travel history.  
 
Case Presentation 
A 48-year-old female was transferred to our facility with a five-day history of fever and 
headache. She was originally from Zambia and had recently traveled to the Democratic Republic 
of Congo (DRC) and Liberia. She reported having a mosquito bite while in the DRC but no 
fevers at that time. She arrived in the U.S. two days prior to fever onset. The first day she noted 
fevers and headache. She presented to an outside hospital where a broad infectious workup was 
performed including tests for bacterial and viral pathogens as well as thick and thin smears for 
malaria. All tests were negative. She returned to the clinic three days later with similar symptoms 
and was admitted with fever and tachycardia. Infectious workup, including a second malaria 
smear, was again negative. She was subsequently transferred to our facility for additional 
workup. She denied other infectious symptoms including cough, nausea, vomiting, dysuria, 
hematuria, hematochezia, myalgias, arthralgias, fatigue, or night sweats. She stated the fevers 
and headache occurred daily. She denied new sexual contacts or drug use. She had no significant 
past medical history other than a remote history of malaria 25 years ago. Physical exam was 
remarkable for a febrile, uncomfortable appearing, middle-aged woman. Labs were notable for 
anemia, lactic acidosis, and elevated ESR/CRP. Blood and urine cultures and RVP were 
negative. A rapid antigen test was positive for P. falciparum. A third malaria smear confirmed 
the diagnosis and demonstrated 4.3% parasitemia. The patient was started on Atovaquone-
Proguanil based on CDC recommendations. She responded rapidly to therapy and subsequent 
testing for the presence of parasite was negative. 
 
Conclusions 
The malaria antigen test can provide a rapid diagnosis and ensure the quick delivery of 
appropriate treatment. It is particularly useful for laboratory technicians who are not familiar 
with performing malaria smears. Thick and thin smears are useful for confirming the detection of 
the parasite, species identification, and quantification of parasite load. Negative smears can be 
seen early in the infection, particularly in non-immune individuals as symptoms can manifest at 
very low levels of parasitemia. Smears should be repeated every 12-24 hours for three sets before 
effectively ruling out malaria. Treatment should be based on identified species, geographic 
related resistance patterns, and clinical severity.  
7 
 
Lumbar Radiculopathy and Iliopsoas Abscess as  
Presenting Manifestations of Ruptured Appendicitis 
David Rayan, Gillian Dryton, Anita Moudgal, B.A., M.Ed., Amanda Jobe, M.D.,  
Radhika Gupta, MBBS, Bharata Lankachandra, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Appendicitis has been called ‘the great mimicker’ due to variability in clinical presentation 
and in orientation of the appendix itself. We report a case of a middle-aged male who had an 
unusual presentation of appendicitis resulting in a delay in diagnosis and further medical 
complications.  
 
Case Presentation 
Patient is a 58-year-old male with a history of chronic back pain and cecal tubulovillous 
adenoma who presented to the ED with chronic lower back pain with associated right-sided 
radicular symptoms for one month, fevers for one week, and areas of swelling in his right lower 
back and buttocks for two days. He had been following with a pain specialist for presumed 
lumbar radiculopathy. An MRI was eventually obtained which showed concern for an iliopsoas 
abscess, so he was directed to the ED for further evaluation. On presentation, a CT scan of the 
abdomen and pelvis and later an MRI of the pelvis were obtained. Imaging demonstrated a large 
right iliopsoas abscess with erosion into the right iliac crest and a right gluteal abscess, likely the 
result of a ruptured retrocecal appendix. The patient was started on Vancomycin and Zosyn, and 
General Surgery was consulted who recommended IR drainage. IR placed drains into both 
abscesses and cultures from the iliopsoas abscess were positive for Bacteroides fragilis and 
Fusobacterium nucleatum. He was treated with a long course of antibiotics. Due to prior history 
of tubulovillous adenoma, repeat colonoscopy was performed which demonstrated an ileocecal 
mass with pathology consistent with invasive adenocarcinoma. He later underwent right 
hemicolectomy with operative report notable for a cecal mass, large mesenteric lymph nodes, 
and thickened and dilated appendix with dense adhesions of the ileocecal junction and appendix 
to the retroperitoneum. Patient established with Oncology and is receiving chemotherapy with 
FOLFOX.  
 
Conclusions 
Classically, appendicitis is described as presenting with periumbilical pain radiating to the 
lower right quadrant. However, when the appendix is located retrocecal, this may not be the case. 
In retrocecal appendicitis, inflammation tends to evolve slowly and abdominal pain may be 
minimal due to coverage of the appendix by the cecum. When pain is present, it often presents in 
a posterolateral distribution, which increases the risk of complications such as a retroperitoneal 
abscess as seen in this case. Abscesses have been reported to occur in 3.8% of individuals with 
appendicitis. Diagnostically, ultrasound has been the first-line imaging modality for assessing 
appendicitis. However, CT is often required to assess complex cases. Studies have shown that 
compared to ultrasound, CT has improved sensitivity and specificity. Given the patient’s 
unconventional presenting symptoms, analysis of imaging in line with physical examination 
findings was critical to establish the etiology of symptoms, diagnosis, and guide management.  
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Determination of Antimicrobial Prescribing Practices 
in an Integrated Health System Emergency Department 
John Price, Sarah Sartain, M.D., Brooke Bitner, Pharm.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Healthcare improvement is constant. Communication gaps can exist between institutions and 
the communities served. Antibiotic stewardships play a key role in minimizing antibiotic usage 
and preventing resistance in hospitals and associated clinics by systematically reviewing 
patients’ data. Antibiotic stewardships utilize interprofessional collaborative practices including 
professionals from medicine, pharmacy, nursing, social services, and clinical laboratory 
scientists to proactively identify potential problems. A tertiary care, integrated health system’s 
Emergency Department (ED) wants to identify antimicrobials prescribed into the outpatient 
community. The primary goal is determining the number of oral antimicrobial prescribed to adult 
outpatients (18+) within a 5-14 day treatment window. Secondary goals include the diagnosis, 
and non-capsule/tablet antimicrobial prescriptions to non-adults, or outside the treatment 
window. 
 
Methods 
This quality improvement study is a pilot, prospective evaluation. Patients are identified via 
the report: “ED Recently Discharged and NOT admitted Patients” over 30 days in the summer of 
2017. Other project inclusions are prescribed antimicrobial(s) and “discharged from ED”.  
Exclusions to this project include: “admission to the hospital” and antimicrobial hypersensitivity. 
 
Results 
Total antimicrobials prescribed over thirty days is 653. Adults prescribed oral antimicrobials 
are 467 (15.6 daily). Patients are diagnosed with infections including: urinary tract, cellulitis, soft 
tissue injury, abscess, upper respiratory, dental caries, gastrointestinal, sexually transmitted, 
otitis, pneumonia, viral, pyelonephritis, tick-borne, fungal, Bell’s Palsy, and sepsis. The number 
of non-adult, non-oral, and outside window treatment antimicrobials are 186 (6.2 daily). 
 
Conclusions 
With 67,000 patients annually, or 184 patients daily, treated in the ED, approximately 11.9% 
receive an antimicrobial treatment on discharge. These antimicrobials treat 16 different forms of 
infection. Limitations and potential future studies include seasonal variability, whether the 
patient obtained prescription, and complied with treatment. 
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Bone-Marrow Sarcoidosis in a Patient Presenting with Fever of Unknown Origin 
Sanjay Parashar, Jesse Richards, D.O., Megan Krause, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Sarcoidosis is an idiopathic granulomatous disease commonly affecting the lungs and 
thoracic lymphatics. Bone marrow involvement is infrequent in sarcoidosis and may be 
associated with anemia and leukopenia. This case report is unique in that sarcoidosis was 
diagnosed from a bone marrow biopsy in the absence of other locations of organ involvement 
during the workup of a fever of unknown origin (FUO). 
 
Case Presentation 
A 57-year-old white male with a history of hyperlipidemia, cholecystectomy, lumbar fusion 
of L4-S1, and recurrent fevers of 102˚F for several months presented with fatigue, myalgia, 
weight loss, and chills. On admission, he had a leukocytosis of 14,000, elevated ESR of 116, 
elevated CRP of 21, elevated ferritin of 509, and low hemoglobin of 10.9. Blood cultures 
returned negative while a PET scan showed enlarged hypermetabolic periportal lymph nodes 
with concern of metastatic disease. Endoscopic ultrasound, fine needle aspirate, and flow 
cytometry of the lymph nodes found no obvious lesions and showed no evidence of malignancy. 
He was referred to orthopedic surgery due to recurrent back pain and his spine implant was 
removed due to concern of infection. Samples of the bone showed bone necrosis with 
granulation tissue, fibrosis, and mild chronic inflammation with negative cultures. The patient 
was discharged but returned less than a month later, presenting to the ED with chest pain. 
Troponin and EKG were negative, however, a chest x-ray showed bilateral opacifications with 
concerns of pneumonia and the patient was admitted. A CTA showed bilateral upper lobe 
alveolar opacities and bronchoscopy revealed no malignant cells or alveolar hemorrhage. A 
positive ANA was noted along with a positive PR-3, however, c-ANCA was negative and the 
PR-3 was trending downwards. Additionally, ACE and Vitamin D 1,25 levels were normal. The 
patient was discharged on multiple course of antibiotics that were unsuccessful in controlling his 
fever. A bone marrow biopsy, ordered due to persistent anemia and thrombocytopenia, revealed 
hypercellular bone marrow (80% for age) and several non-caseating granulomata. A diagnosis of 
sarcoidosis was made, and the patient was placed on prednisone 40 mg/day with improvement of 
symptoms and continual follow up. 
 
Conclusions 
Extrapulmonary bone sarcoidosis is a rare finding. Granuloma formation within bone marrow 
may cause the release of pro-inflammatory cytokines that may cause recurrent fevers, and, like in 
this case, present as a fever of unknown origin. Similarly, the bone marrow remodeling that may 
occur during sarcoidosis may manifest as myalgia and fatigue due to impaired hematopoiesis. 
Several studies have postulated that bone marrow involvement may be more likely in sarcoidosis 
patients who present with abnormal hematological parameters. While statistically low in 
likelihood, sarcoidosis should be considered in patients who have fever of unknown origin, 
especially once an exhaustive infectious and oncological work-up has taken place.  
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Babesiosis in an Immunocompromised Patient 
Sonya Parashar, M.D., Rachel Weihe, M.D., Jessica Newman, D.O. 
KU School of Medicine-Kansas City 
 
Introduction 
In the United States, Babesia microti’s reservoirs include white-footed mice, vole, and deer. 
The vector is the Ixodes scapularis nymph and is commonly seen in spring and summer in the 
Northeast and upper Midwest United States. Risk factors for severe disease include: age > 50 
years old, asplenia, HIV, malignancy, and immunosuppressive therapy exposure, namely with 
TNF-α inhibitors and exposure to rituximab. This case presents a compelling presentation of 
babesiosis and extended treatment course in an immunocompromised patient. 
 
Case Presentation 
A 62-year-old man with a history of chronic lymphocytic leukemia presented with a three-
week history of daily episodes of 103˚F fever and abdominal pain. He previously completed five 
cycles of chemotherapy with bendamustine and rituximab. During his last cycle of 
chemotherapy, he developed increasing left upper quadrant pain, fatigue, and anorexia and had 
progressive splenomegaly. He underwent laparoscopic splenectomy and pathology showed 
extramedullary hematopoiesis with no malignancy. Following splenectomy, he developed fever 
with progressive leukopenia (WBC 2.4 with ANC 1800) and was treated with cefepime and 
vancomycin without improvement. Extensive infectious workup was unrevealing though 
ultrasound suggested possible cholecystitis and a percutaneous drain was placed with no growth 
from gallbladder fluid. Antibiotics were broadened to meropenem, tobramycin, and amphotericin 
B without defervescence. He developed septic shock and was transferred to our institution. A 
thorough exposure history was taken, noting he lived on a wooded property outside Lawrence, 
Kansas and had a lake home in Wisconsin (last visited nine months prior). He often trapped 
raccoons on his property. Laboratory revealed hemolytic anemia, with hemoglobin 6.1 grams, 
haptoglobin < 30, LDH 3871, total bilirubin of 9.7, and AST of 296. A peripheral blood smear 
revealed 50% parasitemia and Babesia microti PCR was later positive. The patient was treated 
with two exchange transfusions reducing parasitemia to less than 5% resulting in rapid 
improvement and was started on azithromycin and atovaquone for a total of six weeks with 
repeat negative smears. Three months after therapy, he had recurrent fever with low levels of 
parasitemia. This resolved after a six-month course of atovaquone-proguanil and azithromycin.  
 
Conclusions 
This patient’s advanced age, asplenia, malignancy, and treatment with bendamustine and 
rituximab were risk factors for severe babesiosis and contributed to his extended treatment 
course. Studies have recently discovered that ongoing antimicrobial exposure in relapsed cases 
result in acquired resistance to both atovaquone and azithromycin. Case reports have shown 
success with achieving clinical cure with the use of atovaquone-proguanil and azithromycin over 
a six-month period in such cases of acquired resistance, which proved to be effective for this 
patient. Though raccoons may carry babesia, the PCR for babesia microti suggested he was more 
likely exposed in Wisconsin with disease resting in a dormant stage until his splenectomy.  
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BMP Signaling Regulates Support Cell Proliferation  
in the Regenerating Zebrafish Neuromast 
Madeline St. Peter, Linjia Jiang, Ph.D., Tatjana Piotrowski, Ph.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Deafness is a debilitating condition that is often caused by sensory hair cell (HC) death in the 
inner ear. Mammals do not have the capacity to regenerate HCs, therefore, cell death due to 
noise exposure, aging, chemotherapeutic drugs, or antibiotics can result in permanent hearing 
loss. In contrast, non-mammalian vertebrates such as the zebrafish can robustly regenerate HCs 
after injury. Zebrafish HCs are located inside neuromasts, which are small, circular organs that 
span both sides of the fish. HCs in the neuromast are surrounded by multiple sub-populations of 
support cells (SCs), each with different proliferative capacities. Following HC death, some will 
divide and differentiate into new HCs, some will self-renew to replenish the SC pool, and some 
will remain quiescent. While the molecular cues responsible for the differentiation of SCs into 
HCs start to be well understood, the genetic mechanisms responsible for SC self-renewal remain 
unexplored. In zebrafish, the bone morphogenic protein (BMP) pathway has been implicated as a 
key regulator of cell proliferation during both embryonic development and regeneration of some 
mature tissue types. We thus hypothesize that BMP signaling regulates SC proliferation in the 
neuromast both in homeostasis and during regeneration.  
 
Methods 
In order to test our hypothesis, we overexpress a BMP ligand using a transgenic heat shock 
line (tg:hsbmp2b) and show that activation of the BMP pathway thwarts SC self-renewal 
following drug-induced HC death.  
 
Conclusions 
Using an in situ hybridization screen, we are currently identifying targets of the BMP 
pathway to better understand how BMP signaling controls SC proliferation in the neuromast.  
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Acquired Factor VIII Inhibitor Related Retropharyngeal Hematoma: 
A Novel and Rare Differential for Acute Dysphagia and Odynophagia 
Ryan Zwick, Jesse Richards, D.O., Ben Fangman, M.D., Abebe Abebe, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Retropharyngeal hematoma is a serious complication of acquired factor VIII inhibitor that 
has not been previously described in literature. Due to the possibility of acute decompensation in 
these patients due to airway compromise, timely diagnosis and treatment is vital.  
 
Case Presentation 
A 56-year-old man with past medical history of spinocerebellar ataxia presented to the 
Emergency Department with odynophagia, dyspnea, and facial swelling. He first noticed a sore 
throat two days prior and decided to come to the ED when he could no longer swallow liquids. In 
the ED, diffuse ecchymosis across his upper extremities was noted. Initial labs revealed elevated 
WBC (18.8 K/µL), decreased hemoglobin (7.5 gm/dL), normal INR 1.1, but prolonged aPTT 
that did not correct with a 1:1 mixing study. Due to concern for an impending upper airway 
compromise, direct laryngoscopy was performed which revealed a large posterior pharyngeal 
wall mass with 80% obstruction of the larynx. Urgent CT revealed odontogenic infection and 
soft tissue thickening in the pharynx and larynx likely secondary to infection rather than tumor or 
hemorrhage. Broad spectrum antibiotics were started, and he was admitted to the Medical 
Intensive Care Unit for airway monitoring.  
On arrival to the MICU, repeat laryngoscopy was interpreted as pharyngeal hematoma. 
Coagulation factor assay was performed which revealed decreased factor VIII. Mixing study did 
not correct aPTT that was compatible with an acquired factor VIII inhibitor. Based on this 
finding, he was started on prednisolone and cyclophosphamide. Gradual improvement in aPTT 
followed with eventual resolution of the hematoma. He was then discharged with follow up. 
 
Conclusions 
This case serves to remind that a retropharyngeal hematoma is an important consideration in 
the differential diagnosis of acute odynophagia and dysphagia. Although rare in incidence, a 
retropharyngeal hematoma can compromise the airway making its recognition and management 
urgent. This case also introduces acute odynophagia and dysphagia as presenting symptoms of 
acquired factor VIII inhibitor. Acquired factor VIII inhibitor is a rare disorder that typically 
presents with catastrophic bleeding episodes later in life. Unlike congenital factor VIII inhibitor 
which commonly presents with hemarthrosis, acquired factor VIII inhibitor presents with 
purpura or soft tissue bleeding including retropharyngeal hematoma. Due to its diagnostic 
challenge, acquired factor VIII inhibitor carries significant morbidity and mortality (mortality 
rate up to 22%).  
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Risk of Lead Dislodgement with Catheter Ablation in Patients with Recently Implanted 
Cardiac Implantable Electronic Device 
Brendan Cokingtin, Mohammad-Ali Jazayeri, M.D., Kevin Cokingtin,  
Venkat Vuddanda, M.D, Courtney Jeffery, APRN-C, Donita Atkins, BSN 
KU School of Medicine-Kansas City 
 
Introduction 
Patients with cardiac implantable electronic devices (CIEDs) frequently have arrhythmias 
warranting catheter ablation (CA). The risk of lead dislodgement with CA in patients with CIED 
implant within one year is uncertain. We retrospectively evaluated patients undergoing CA of 
arrhythmias at an academic medical center with CIED implant, lead revision, or upgrade within 
the preceding year.  
 
Methods 
We assessed rates of CIED-related mechanical complications and infection over six-months 
follow-up. Pre-/post-ablation device interrogations were reviewed for interval changes and 
parameters compared with the Wilcoxon Signed-Rank test.  
 
Results 
Among 1810 CIED patients undergoing CA from 2012-17, 170 had CA within 12 months of 
CIED implant, lead revision, or upgrade. Median age was 69 years, and 68% were men. 
Implantable cardioverter defibrillators and cardiac resynchronization therapy devices were each 
present in nearly 25% of patients. Median time to CA was 138 days; 50 (29%) and 12 (7%) had 
CA within 90 and 30 days of CIED procedures, respectively. One atrial lead required revision 
after dislodgement during atrial fibrillation CA 190 days after CIED upgrade. No CIED 
infections, other mechanical complications, or clinically significant changes in device function 
were observed.  
 
Conclusions 
CA of arrhythmias in patients with CIEDs appears safe with a very low risk of lead 
dislodgement, even in those with device implant/upgrade 90 days or less pre-ablation.  
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Nelson's Syndrome:  
A Rare Treatment-Related Complication of Refractory Cushing’s Syndrome 
Anam Abbasi, M.D., Sachin Srinivasan, M.D., Georges Elhomsy, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Nelson’s syndrome is a rare neuroendocrine condition described as a complication of 
bilateral adrenalectomies undertaken for refractory Cushing’s syndrome. It is seen in about 8-
47% of patients after the procedure. Nelson’s syndrome refers to a spectrum of symptoms and 
signs arising from an adrenocorticotropic (ACTH)-secreting pituitary macroadenoma after 
therapeutic bilateral adrenalectomy. The observed spectrum of clinical features relates to the 
local effects of the tumor on surrounding structures, the secondary loss of other pituitary 
hormones, and the effects of the high serum concentrations of ACTH on the skin. 
 
Case Presentation 
A 25-year-old female with a past medical history of hypertension, hyperlipidemia, and type 2 
diabetes presented with 150-pound weight gain in two years associated with fatigue, increased 
appetite, polyuria, polydipsia, constipation, amenorrhea, decreased libido, constipation, bruising, 
headache, and somnolence. She was obese and had hirsutism, severe acne, acanthosis nigricans, 
abdominal stretch marks without characteristic purple striation, and elevated BP. Labs showed a 
normal thyroid function test, IGF1, and prolactin, elevated morning cortisol level, and a positive 
dexamethasone suppression test. 24-hour free urinary cortisol was high. Elevated corticotropin, 
midnight salivary cortisol, and ACTH confirmed Cushing's syndrome. Pituitary MRI revealed a 
hypo-intense adenoma on the left side of sella, close to the left internal carotid artery. She was 
recommended for resection of a pituitary adenoma but deferred it to preserve fertility. CT chest, 
abdomen, and pelvis ruled out sources of ectopic ACTH production. Treatment proceeded with 
bilateral adrenalectomy for persistent Cushing’s syndrome followed by supplementation with 
fludrocortisone, dexamethasone, and tapering prednisone. At one-month post-adrenalectomy, she 
had lost 40 pounds but reported persistent headaches, fatigue, polyuria, and polydipsia. Her 
ACTH level remained elevated. MRI brain showed an interval increase in size of the pituitary 
adenoma without mass effect on optic chiasm. This macroadenoma combined with her 
symptoms and an even higher post-surgical ACTH favored the diagnosis of Nelson’s syndrome. 
She underwent gamma-knife radiation therapy for the pituitary adenoma without any 
complications.  
 
Conclusions 
Predictive risk factors of Nelson’s syndrome include existing pituitary macro-adenomas, lack 
of prophylactic radiation at the time of adrenalectomy, duration of Cushing’s disease, rapid rise 
of ACTH in the first year after surgery, and high urinary cortisol levels. Pathophysiology 
involves uninhibited corticotropin releasing activity leading to increased ACTH, 
propiomelanocotrin, and by-products. This leads to increased ACTH, tumor progression with 
compression on cranial nerves optic pathways leading to hyperpigmentation, oculomotor nerve 
palsies, hemianopsia, and possibly blindness. Treatment options include observation, surgery, 
radiation, and/or pharmacotherapy. Given the significant morbidity associated with this 
condition, prompt detection and treatment are necessary to prevent further devastating 
complications. 
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Transgender Health Medical Education Intervention  
and its Effects on Beliefs, Attitudes, Comfort, and Knowledge 
Joseph Cherabie, M.D., Kari Nilsen, Ph.D., Sarah Houssayni, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Transgender health disparities have been well documented in the literature in recent years, as 
have the lack of transgender health issues in medical education programs across the country. 
Currently, there is little to no transgender health medical education within the University of 
Kansas School of Medicine-Wichita. 
 
Methods 
A prospective study was conducted with an hour-long didactic lecture on transgender health 
being given to faculty, medical students, and residents at the University of Kansas School of 
Medicine-Wichita. The didactic lecture included educational information and presentations by 
transgender persons. A pre-intervention and post-intervention survey was given to assess 
attitudes, comfort level, knowledge, and beliefs regarding the treatment of transgendered persons 
and associated health concerns, as well as a 90-day post-intervention survey assessing the same 
variables. The question of what attendees planned to do differently as a result of the intervention 
was asked. 
 
Results 
The intervention provided a significant positive increase in attitudes, comfort levels, and 
knowledge with respect to transgender health issues between the pre- and post-intervention 
surveys, however, did not provide a significant positive increase in beliefs on transgender health 
issues. There was no significant change in attitude, comfort levels, knowledge, or beliefs from 
the post-survey after 90 days. Four categories of what attendees planned to do differently as a 
result of the intervention also were identified. 
 
Conclusions 
A didactic lecture on transgender health issues can positively change attitudes, comfort 
levels, and knowledge on transgender health issues significantly with the changes sustaining 
after 90 days. Beliefs tend to be much harder to change.  
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Effective Management of Obesity with Generic Combination  
of Phentermine/Topiramate vs Qsymia®: Is it Possible? 
Wajeeha Rizvi, M.D., Nicholas Ojile, M.D., Milan Bimali, Ph.D., K James Kallail, Ph.D., 
Georges Elhomsy, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Obesity is a significant health concern in the developed world, with nearly 40% of the 
worldwide population estimated to be overweight and 13% meeting World Health Organization 
criteria for obesity in 2016. Medical management is needed in patients who are unable to attain 
ideal weight loss with conservative methods and lifestyle modification. In this study, we assessed 
if the less-expensive generic combination of phentermine and topiramate is an effective 
alternative weight loss medication. 
 
Methods 
A retrospective, cross sectional, observational study was conducted on all eligible patients at 
a university endocrinology clinic to compare the weight changes among users of Qsymia® versus 
those who took a combination of generic phentermine and topiramate. Medical records were 
abstracted for relevant data including weight, vital signs, and relevant lab data. 
 
Results 
Seventy-three eligible patients were analyzed (17 who took Qsymia® and 56 who took 
phentermine/topiramate). The number of weight measurements recorded per patient ranged from 
1 to 10. There were no statistically significant differences in age, sex, and race/ethnicity. The 
distribution of A1c, LDL, HDL, TSH, T4, and duration of drug use were comparable across the 
two groups. Generalized estimation equation-based modeling estimates revealed no significant 
difference in weight measurements between the two groups in the unadjusted as well as each of 
the three adjusted models. Modeling on median imputed data revealed similar findings. 
 
Conclusions 
A generic combination of phentermine and topiramate provided similar weight loss results as 
the more expensive alternative, Qsymia®. This observational study warrants the need for a larger 
study to verify that the less expensive medication can be provided for weight loss.  
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Polyarticular Calcium Pyrophosphate Deposition Disease  
Masquerading as Pseudoseptic Arthritis 
Sarah El Chami, M.D., Timothy Shaver, M.D., Paul Ndunda, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Calcium pyrophosphate dihydrate (CPPD) disease is the second most common crystal-
induced arthropathy. The acute form of the disorder, pseudogout, occurs in one fourth of patients 
with CPPD. Pseudogout has a heterogenous presentation that can mimic other causes of severe 
joint inflammation including rheumatoid arthritis, osteoarthritis, and septic arthritis. Our case of 
polyarticular pseudogout presented as pseudo-septic arthritis.  
 
Case Presentation 
A 64-year-old male with a medical history of recurrent mantle cell lymphoma, COPD, and 
type 2 diabetes presented for acute left shoulder pain. Six weeks prior, the patient was admitted 
for right wrist pain and swelling. Irrigation and drainage of the right wrist revealed purulent 
synovial fluid; gram stain showed many WBCs with no organisms; and there was no growth on 
synovial fluid or blood cultures. The patient was diagnosed with presumed septic arthritis and 
was discharged on a six-week course of IV antibiotics.  
After taking antibiotics, the patient presented with left shoulder pain after lifting a heavy 
object. The patient was started empirically on IV antibiotics for possible septic arthritis. Vital 
signs were T 37.3o C, HR 113 bpm, and BP 144/86 mmHg. Examination of the left shoulder 
revealed anterior tenderness with limited abduction and flexion. White blood count was 13,600 
cells/μl with 83% neutrophils and ESR and CRP were elevated at 44 mm/hr and 22.9 mg/l, 
respectively. Aspiration of the left shoulder revealed 71,000 RBCs, 18,540 WBCs, and calcium 
pyrophosphate crystals. Gram stain showed no organisms and viral, bacterial, and fungal cultures 
revealed no growth. Later, the patient developed left wrist and right ankle pain and swelling. 
Examination revealed bilateral diminished range of motion with extensive synovitis/ 
tenosynovitis, warmth, and tenderness. Synovitis was present in right and left metacarpo-
phalangeal diffusely, with tenderness over right 2nd-5th metacarpophalangeal, 2nd-3rd proximal 
interphalangeal joints, left 2nd-5th metacarpophalangeal joints, and 2nd-4th proximal phalangeal 
joints. Feet were negative for synovitis but positive for tenderness in bilateral 2nd-3rd 
metatarsophalangeal joints. Aspirate of the left wrist was dry and radiographs demonstrated 
radiocarpal narrowing with chondrocalcinosis in the triangular fibrocartilage distribution. The 
patient was diagnosed with pseudogout. Antibiotics were discontinued. The patient was started 
on colchicine and steroids, which led to immediate and dramatic improvement. 
 
Conclusions 
Pseudoseptic arthritis describes a clinically expressive septic joint with purulent aspirate 
when no microorganisms can be isolated. It can be caused by several inflammatory conditions 
and is indistinguishable from true septic arthritis. Fourteen percent of patients diagnosed with 
septic arthritis that had negative bacteriological results subsequently developed rheumatic 
disease. When no microorganism is identified, the diagnosis of septic arthritis should remain 
presumptive and further evaluation should screen for other diseases, especially those of 
rheumatologic origin.  
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Elevated Procalcitonin with Atypical Presentation 
Rachel Sigler, D.O., Kassem Hammoud, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Procalcitonin is a marker of bacterial infection, commonly used to distinguish community 
acquired pneumonia due to bacterial causes versus viral etiologies. We report a case of elevated 
procalcitonin in a patient with autoimmune disease and anakinra withdrawal.  
 
Case Presentation 
A 22-year-old male with systemic juvenile idiopathic rheumatoid arthritis presented to an 
outside hospital for evaluation of muscle and joint pain. He was treated with anakinra previously, 
but ran out of his medications five days prior. At the outside hospital, he reported a cough and 
had chest radiograph with concern for left lower lobe pneumonia. He was started on levofloxacin 
and transferred to KU for rheumatology evaluation. At the time of his presentation, his WBC 
count was 32000, with 13% bands, and a procalcitonin of 5. A CT chest demonstrated a small 
subpleural consolidation. Rheumatology started plaquenil and prednisone 5 mg for one week. 
Patient spiked a fever of 100.4 on hospital day six and ID was consulted. Blood cultures at 
outside hospital were negative, as were cultures obtained on admission. Vancomycin was started 
as patient continued to have nightly febrile episodes. On hospital day 10, procalcitonin was 28 
and continued to rise over the next two days, peaking at 42 in spite of broad-spectrum 
antimicrobial coverage with linezolid, meropenem, and liposomal amphotericin B. Extensive 
infectious work-up was negative. Patient underwent bronchoscopy, which revealed rhinovirus 
infection. Anakinra was resumed and his antimicrobials were stopped. The procalcitonin and his 
WBC count rapidly decreased and his fever resolved by the next day.  
 
Conclusions 
Procalcitonin is produced by neuroendocrine cells in the thyroid and lungs, most of which is 
converted to calcitonin. It is encoded by gene CLAC-1 on chromosome 11. Bacterial infections 
increase CALC-1 expression on parenchymal tissue, which leads to procalcitonin that is not 
converted to calcitonin peripherally. Viral infections have less effect on procalcitonin levels due 
to interferon gamma expression. Infections associated with TNF alpha release, such as gram-
negative infections and malaria, have the highest procalcitonin levels. Infections that trigger 
different inflammatory pathways, such as Lyme disease and mycobacterial infections, do not 
increase procalcitonin levels. In this case, procalcitonin was falsely elevated, likely due to 
anakinra withdrawal. His symptoms started within days of stopping the medication, which is not 
typical for autoimmune disease flair. Although procalcitonin has shown clinical utility in 
distinguishing bacterial infections from viral, it is important to remember its limitations in the 
hospital setting. Procalcitonin can be helpful in cases of lower respiratory tract infections and 
deciding when to de-escalate or discontinue antibiotics.  
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Polymicrobial Endocarditis 
Joseph Borick, M.D., Thomas Moore, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Polymicrobial endocarditis (PE) is becoming more common and can occur in 1-7% of 
patients with endocarditis. It disproportionately effects intravenous drug users (IVDU) and is 
more likely to have a fatal outcome. The patient’s history can provide essential clues to guide the 
provider in decision making. Analysis of the choice of illicit drug and method of injection can 
hint to the most likely organism and may necessitate fungal cultures.  
 
Case Presentation 
A 28-year-old female with history significant for IVDU and pregnancy (24 weeks) presented 
with three weeks of hip pain followed by progressive leg weakness, shortness of air, hemoptysis, 
and fevers. She used methamphetamine, hydromorphone and marijuana. When she used IV 
drugs, she often used tap water for dilution and shared needles.  
Hospital labs were significant for anemia, thrombocytopenia and leukocytosis. A CTA chest 
was performed and showed innumerable thick walled cavitary lesions consistent with septic 
emboli. She was admitted to the ICU and started on Vancomycin and Piperacillin-Tazobactam. 
Blood cultures were drawn and were positive in 2/2 vials for methicillin-sensitive 
Staphylococcus aureus. Piperacillin-Tazobactam was discontinued and Vancomycin was 
changed to Nafcillin. ECHO was significant for tricuspid valve vegetation. Fungal cultures 
eventually grew Aspergillus fumigatus. She was started on Amphotericin and switched to 
Voriconazole after risks to infant were discussed. Repeat fungal cultures on hospital day 10 also 
were positive for Aspergillus fumigatus. On hospital day 11, she went into pulseless electrical 
activity and a perimortem c-section was performed at bedside. Her daughter was delivered and 
transferred to the NICU. There was return of spontaneous circulation but she was made comfort 
care after MRI showed severe hypoxic ischemic injury and she passed away on hospital day 18. 
Three months later, her daughter was discharged from the NICU with her grandmother.  
 
Conclusions 
While Staphylococcus aureus is most common organism in IVDU, oral flora is associated 
with patients who lick their needles/skin. Candida is associated with patients who use brown 
heroin dissolved in lemon juice. Pseudomonas is associated with using pentazocine-
tripelennamine and Aspergillus is associated with dissolving drugs in tap water. Aspergillus is 
found in 6-55% of water samples. Of the above, Aspergillus is unique as blood cultures are 
rarely positive, necessitating fungal cultures. Delayed or mistaken diagnosis and extra cardiac 
manifestations occur in the majority of cases of endocarditis with Aspergillus. Diagnosis of 
Aspergillus endocarditis requires a high clinical index of suspicion and mortality rates approach 
80%. In the appropriate patients, fungal cultures should be obtained even when blood cultures 
are positive for other organisms, such as Staphylococcus aureus, as polymicrobial infections can 
occur. Our case manifests the necessity in obtaining fungal cultures in IVDU who utilize tap 
water in their drug use process. 
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Ice Induced Cardiac and Systemic Thrombus 
John Eliveha, M.D., Shravani Vindhyal, M.D., Mohinder Vindhyal, M.D., M.Ed. 
KU School of Medicine-Wichita 
 
Introduction 
Methamphetamines (ICE) are sympathomimetic amines that increase synaptic concentration 
of serotonin, noradrenaline, and dopamine, creating hallucinogenic, euphoric, and stimulant 
effects. Cardiovascular complications are the second leading cause of death in methamphetamine 
users. The cardiac complications of methamphetamines are hypothesized from a variety of 
mechanisms such as hypertension, tachycardia, and myocardial toxicity with cellular death, 
fibrosis, and contraction band necrosis. We present a case of ventricular thrombus with systemic 
emboli in a patient with dilated cardiomyopathy after methamphetamine use.  
  
Case Presentation 
A 24-year-old female with history of AIDS, non-ischemic cardiomyopathy, and 
polysubstance abuse presented with acute onset lower extremity pain. The patient had snorted 
methamphetamine overnight. She woke up with severe lower extremity pain and inability to 
move her lower limbs. Her vital signs showed tachycardia, tachypnea, and hypotension. 
Examination was positive for tender lower extremities with no palpable dorsalis pedis, posterior 
tibial, and popliteal pulses bilaterally. Initial lab tests were significant for lactic acidosis, acute 
kidney injury, non-specific ST-T wave changes, elevated troponin, and urine drug screen 
positive for methamphetamine and marijuana. Arterial and venous duplex of the lower 
extremities revealed no blood flow. CT angiogram showed large segment aortic occlusion (4 cm) 
just beyond the renal arteries. Transthoracic echocardiogram showed an echo dense mass in the 
left ventricle with defined margins that were distinct from the endocardium and seen throughout 
systole and diastole showing left ventricular thrombus. 
 
Conclusions 
Factors causing ventricular and systemic thrombus in patients following methamphetamine 
abuse involve the size of myocardial infarct and extent of systolic dysfunction. Usually patients 
with decreased ejection fraction are at a higher risk for thrombus after unrecognized myocardial 
infarction. The formation of thrombus occurs within 24 hours post myocardial infarction. With 
the increasing prevalence of methamphetamines use, primary care physicians should be aware of 
complications such as cardiac and systemic thrombus.  
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Non-Atherosclerotic Coronary Angina 
Shravani Vindhyal, M.D., John Eliveha, M.D., V. Subbarao Boppana, M.D.,  
Mohinder Vindhyal, M.D., M.Ed. 
KU School of Medicine-Wichita 
 
Introduction 
Coronary artery fistula (CAF) is an abnormal communication between an epicardial coronary 
artery and a cardiac chamber or a major vessel (vena cava, subpulmonary veins, pulmonary 
artery, mediastinal vessels, or coronary sinus) bypassing the capillary bed. CAFs are mostly 
solitary but at times there could be multiple micro fistulas. CAF incidence is 0.2% to 1.2%, but 
the incidence of CAFs is on the rise over the last decade due to the wide use of echocardiography 
and angiography. CAFs are reported to arise more from the right coronary system than the left, 
and more than 90% drain into the venous circulation. We present a case of CAF in a male 
presenting with chest pain. 
 
Case Presentation 
A 40-year-old Chinese descent male presented to the ER complaining of chest pain. The pain 
was characterized as heavy, retrosternal, and non-radiating associated with dizziness, nausea, and 
palpitations. The pain started while lifting a heavy object in the kitchen and was relieved 
gradually with rest. Similar episodes of chest pain for the past several years limited his physical 
activity but he did not seek medical attention due to lack of medical insurance. Physical exam 
was positive for a continuous grade II/VI murmur at left sternal border, otherwise, lungs were 
clear, jugular venous pressure was normal, and no pedal edema was noted. An exercise stress test 
was terminated prematurely at seven minutes as he developed dizziness, ST-segment depression 
in the lateral leads, non-sustained monomorphic ventricular tachycardia, and a transient left 
bundle branch block. 
Cardiac catheterization showed insignificant coronary artery disease but revealed a fistula 
leading from the left coronary artery near the bifurcation to the main pulmonary artery. Attempts 
to coil the fistula via the pulmonary circulation proved unsuccessful. The fistula was isolated and 
ligated close to the left anterior descending artery. Transesophageal echocardiography was used 
to confirm the flow to the pulmonary artery before and after ligation. This resulted in patient 
recovery without any complications and he remained asymptomatic. 
 
Conclusions 
Patients with CAF often remain asymptomatic. Development of symptoms depends on the 
severity of the left to right shunt and the degree of volume overload produced by the fistula. 
Coronary angiography remains the gold standard for diagnosis. Transthoracic echocardiography 
combined with Doppler color flow imaging, transesophageal echocardiography, magnetic 
resonance imaging, and contrast-enhanced multi-detector tomography can be used as an adjunct 
to coronary angiography. The usual indications for treatment include the proximal location of the 
fistula, a single drain site, extra-anatomic termination of the fistula away from normal coronaries, 
older patient age, and absence of concomitant cardiac disorders requiring surgical intervention.  
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Miliary TB in a Patient with End-Stage Liver Disease 
Victoria Poplin, M.D., Brent Harbaugh, M.D., Nathan C. Bahr, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Miliary tuberculosis (TB) is a rare form of TB that results from massive 
lymphohematogenous dissemination. We present a case of fatal military TB in a patient with 
end-stage liver disease (ESLD).  
 
Case Presentation 
A 52-year-old male with a history of ESLD due to alcohol abuse and type 2 diabetes mellitus 
presented to the emergency department due to multiple falls and confusion. He was recently 
discharged after having been admitted for pneumonia and culture-negative spontaneous bacterial 
peritonitis. On admission, a CT chest showed tiny nodular opacities in all five lobes with upper 
lung predominance and some more prominent patchy alveolar opacities at the lung apices and an 
irregular lytic lesion in the anterior and inferior aspects of the T9 vertebral body. He was also 
noted to have severe thrombocytopenia and altered mental status. The patient was admitted and 
placed in airborne isolation due to concern for possible TB. An interferon gamma release assay 
was obtained and later returned positive. Shortly into his hospital stay, he was started on empiric 
TB treatment with isoniazid, ethambutol, rifampin, and pyrazinamide. After discussion with 
outside TB specialists, isoniazid and pyrazinamide were discontinued and daily levofloxacin and 
three times weekly amikacin were started in setting of his known ESLD. A bone marrow biopsy 
showed multiple granulomas, but special stains were negative for acid fast and fungal organisms. 
Approximately three weeks into his stay, his peritoneal culture from previous hospitalization 
returned positive mycobacterium tuberculosis (MTB) complex and a few days later one sputum 
sample grew MTB complex as well. Lumbar puncture was not able to be obtained due to 
thrombocytopenia although his platelet count did eventually improve after TB therapy initiation. 
By this time, the diagnosis was confirmed. Unfortunately, he went on to develop acute hypoxic 
respiratory failure, worsening mental status and acute renal failure, which ultimately lead to a 
fatal arrhythmia. 
 
Conclusions 
In 2016, approximately 10.4 million people fell ill with TB. Miliary TB is a rare form of 
disseminated TB that affects up to 2% of individuals and carries up to a 33% of mortality. Its 
diagnosis is often delayed as presenting symptoms are non-specific and varies depending on the 
sites involved. The most common symptoms include fever, cough, weight loss, and anorexia. 
The diagnosis of miliary TB involves obtaining tissue/fluid of the sites involved and sending for 
AFB smear and culture. Treatment of military TB has yet to be standardized. Currently, the 
IDSA recommends six months duration for drug susceptibly miliary TB, however, this must be 
extending if there is bone, joint, or meningeal involvement. We suspected both bone and 
meningeal involvement in this patient. Therapy choice was further complicated by his liver 
disease, thrombocytopenia, and eventual renal failure. 
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Paenibacilli - Newly Identified Organism Concealed in an Old Genus 
Tori Kunkel, Jessica Newman, D.O. 
KU School of Medicine-Kansas City 
 
Introduction 
Paenibacillus species are gram-positive bacteria originally classified as Bacillus species until 
the establishment of a new genus in 1993. These organisms typically reside in soil and have been 
identified in diverse environments including honeybee colonies, ocean sediment, and fresh water. 
Organisms of the Paenibacillus genus were not known to cause human disease until recently, 
when scattered case reports of human infections, including bacteremia, osteomyelitis, and 
endocarditis caused by several species began appearing in medical literature. 
 
Case Presentation 
A 23-year-old female with a history of neurogenic bladder status post bladder stimulator 
placement and ulcerative colitis status post colectomy presented to the emergency department 
with fevers, chills, nausea, and discomfort in the left upper extremity at the site of a central line. 
The patient had recently been diagnosed with bacteremia secondary to a gram-positive rod at an 
outside institution. A peripherally inserted central catheter was placed, follow-up blood cultures 
were negative, and she was discharged on intravenous daptomycin 6 mg/kg/day. Final 
identification of the gram-positive rod was pending. On physical examination at our institution, 
the patient was afebrile at 37.6° C, with pulse of 90 bpm, and a normal blood pressure. A 
complete blood count revealed a WBC of 6.8 K/UL with 88% neutrophils. Blood cultures were 
obtained and the central line was removed. An ultrasound of the left upper extremity 
demonstrated a near-completely occlusive thrombus in the left axillary brachial and basilic veins, 
which was treated with enoxaparin. Finalized blood cultures from the previous hospital stay later 
identified Paenibacillus jamilae/polymyxa, and blood cultures at our hospital revealed the same 
isolate. The isolate was resistant to penicillin but susceptible to clindamycin, trimethoprim/ 
sulfamethoxazole, and vancomycin. An attempt to ascertain the source of infection could not be 
confirmed. The patient denied use of intravenous drugs or injection of a foreign substance into 
the venous access site but was concerned about potential exposure from soil in a horse arena she 
frequented. The bladder stimulator generator site was non-tender, and patient declined removal. 
Hospital treatment consisted of intravenous vancomycin and oral trimethoprim/ 
sulfamethoxazole. She was discharged on oral linezolid to complete a 14-day course of therapy. 
 
Conclusions 
Paenibacilli are a newly classified genus of bacteria that were originally categorized as 
Bacillus species. Paenibacilli have been implicated in human infection and have been isolated 
from urine, cerebrospinal fluid, and blood cultures. Paenibacillus polymyxa specifically was 
previously implicated as a causative agent for bacteremia in an elderly patient with cerebral 
infarction who weeded her garden daily. Current methods in clinical microbiology laboratories 
may not be sufficient for identification and more complex analysis may be required for species 
identification. Clinical isolates may be intermediate to penicillin G and quinolones but 
susceptible to trimethoprim/sulfamethoxazole, aminoglycosides, vancomycin and linezolid.  
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Characteristics of Smokers among Patients in a Hepatology Clinic 
Daly Al-Hadeethi, M.D., Victor Ankoma-Say, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
The 2014 Report of the Surgeon General, The Health Consequences of Smoking-50 Years of 
Progress, marks an anniversary since the first Surgeon General’s report on smoking and health. 
In the 1964 and 2004 Surgeon General’s reports, cigarette smoking was associated with diseases 
affecting multiple organs of the body. The most recent report highlighted that the number of 
diseases and other adverse health effects caused by smoking and secondhand smoke have 
increased and that the disease risks are greater than presented in previous reports, including liver 
cancer and colorectal cancer. 
Smoking rates for adults have decreased from about 43% in 1965 to about 18% in 2012. 
Despite significant progress since the first Surgeon General’s report, smoking remains the single 
largest cause of preventable disease and death in the United States, with more than 40 million 
Americans dependent on tobacco smoking. Although the rate of tobacco smoking has declined 
steadily, more needs to be done to prevent and stop smoking. To promote smoking cessation and 
assist tobacco users to quit, smokers visiting health care settings are advised routinely about 
tobacco cessation and are reminded about future consequences of continuing smoking. Providing 
smoking cessation resources to patients in both general and specialty settings would improve the 
efforts and help them to quit. This study described characteristics of smokers in a hepatology 
clinic and provided smoking cessation resources to them according to current guidelines.  
 
Methods 
Data were collected over a period of seven months among patients (age > 18) who attended 
The Liver Associates of Texas clinic and completed the voluntary survey based on the 
Fagerstrom Test for nicotine dependence. Patients who screened positive for smoking were 
provided with both hard copies and on-line patient educational resources to help them to quit. 
Frequency distributions on age, gender, ethnicity, race, BMI, education, diagnosis of interest, 
and the presence or absence of cirrhosis in the study population were performed. Data were 
analyzed using SPSS version 21. 
 
Results 
From 51 patients screened for smoking, 44 were interested in quitting. All 44 were provided 
with both copy and online educational resources. Four decided to try quitting without any 
intervention. Forty decided to quit using pharmacotherapy. Nine used Chantix®, three used 
Bupropion, and the remaining 28 used nicotine replacement therapy (12 prescribed patches, 10 
prescribed gums, and six prescribed lozenges). From 44, 41 (93%) quit after three to six months 
follow-up without relapse. 
 
Conclusions 
Most participants were interested in smoking cessation. These results suggested that smoking 
cessation resources (both hard copy and online educational resources) should be available to 
hepatology patients as part of routine care.  
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Computed Tomography Fractional Flow Reserve: 
An Appropriate Low-Risk Screening Tool for Coronary Disease 
Alexander Robinson, D.O., Nicholas Isom, M.D., Chris Buckley, M.D.,  
Thomas Rosamond, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Left heart catheterization for direct visualization of coronary vessels has been common 
practice for many years. The decision to perform percutaneous coronary intervention (PCI) is 
often based upon the observed percent stenosis in each vessel, and vessels with 70% or greater 
stenosis often have intervention performed. Over the last decade, fractional flow reserve (FFR) 
has gained traction in determining if a lesion is hemodynamically significant. FFR uses direct 
measurement of pressure and flow to determine if the stenosis is truly causing significant 
ischemia, thus giving a more approachable and objective measurement to assist with making the 
decision to intervene. More recently, computed topography fractional flow reserve (CT FFR) 
imaging has allowed physicians to obtain an FFR value without requiring an invasive left heart 
catheterization. As this is a relatively new technique, there is limited data comparing CT FFR 
with direct visualization of left heart catheterization.  
 
Methods 
Seventy-one patients received CT FFR during their care at Kansas University. Of those 71 
patients, 19 patients had a diagnostic left heart catheterization as part of an ischemic workup. 
Seven of those patients had to be excluded due to misalignment, motion artifact, or previous 
stents obscuring the results. The 12 remaining patients had their CT FFRs compared with their 
catheterization results. An FFR result of less than 0.8 was considered to be hemodynamically 
significant, while a stenotic lesion of 70% or more was also determined to be significant. 
 
Results 
Using the guidelines noted previously for determining significant lesions, five of the patients 
were found to have FFR values that were less than 0.8. Three of those patients were found to 
have significant stenosis on catheterization. The remaining seven patients receiving CT scans all 
had non-significant FFR values. All seven of those patients had negative left heart 
catheterizations as well. For purposes of screening or diagnostics, CT FFR was found to have a 
sensitivity of 100% and specificity of 77.8% when compared to gold standard left heart 
catheterization. 
 
Conclusions 
Fractional flow reserve is a technique that has been gaining attention to help distinguish 
whether a stenotic lesion has hemodynamic significance. With this small cohort of patients, CT 
FFR was found to be a potentially useful screening tool for stenotic lesions requiring PCI. This 
could help prevent unnecessary left heart catheterizations which carry risks of bleeding and 
infection.  
 Use of Rituximab in Treatment of Recalcitrant Dermatitis Herpetiformis 
Chisom Eze, M.D., Timothy Shaver, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Dermatitis herpetiformis (DH) is a cutaneous-intestinal disorder caused by hypersensitivity to 
gluten whose treatment has mostly centered around gluten free diet, dapsone, and various 
immunomodulators. There has been recent evidence, however, supporting the use of Rituximab 
in the treatment of recalcitrant DH. This systematic review compiled and assessed evidence 
regarding: a) the mode of action, b) different treatment protocols, c) clinical responses, d) safety 
profile and future directions in B-cell-targeted therapy in treatment of DH. 
Our case involves an 88-year-old male with biopsy proven celiac disease, recalcitrant DH, 
diffuse osteoarthritis, and prosthetic joint infection (on chronic Minocycline) in whom GI 
manifestations of disease had been well controlled with gluten free diet for over 10 years. 
However, diffuse bullous skin manifestations involving the trunk and proximal upper extremities 
have persisted despite Dapsone therapy which was aborted once patient developed 
methemoglobinemia. He then presented to the rheumatology clinic personally requesting 
initiation of therapy with Rituximab following online research regarding its use. 
 
Methods 
A systematic database search according to the PRISMA statement was conducted. Reference 
lists were searched for cases of recalcitrant DH and autoimmune bullous skin diseases treated 
with Rituxan on PubMed, Google Scholar, and EBSCO Health. 
 
Results 
The primary search yielded five articles. Four articles highlighted the use of Rituxan in the 
treatment of autoimmune bullous disease with an emphasis on pemphigoid and epidermolysis 
bullosa acquisita, as they were considered the more treatment unresponsive disorders. Mode of 
action was well described by one article as binding of Rituximab to CD20-expressing B 
lymphocytes leading to destruction of the target cells by a combination of antibody-mediated and 
complement-mediated cytotoxicity and apoptosis. One article provided treatment protocols with 
Rituxan specifically highlighting its use for DH administered at a dose of 375 mg/m(2) IV in 
weekly intervals for four consecutive weeks (lymphoma protocol) in addition to the standard 
immunosuppressive treatment. Clinical response was highlighted in two articles which reported 
use of Rituxan in more than 160 patients with autoimmune bullous dermatosis, with more than 
95% benefiting from the treatment, however, these data did not elaborate on which specific 
diseases. One seminal case report detailed clinical and serological remission with normalization 
of both IgA Transglutaminase G2 and G3 antibody levels in an 80-year-old male with 
recalcitrant DH treated with Rituxan. Three articles described common adverse events of 
Rituxan including infections, lower limb deep vein thrombosis, PE, hypogammaglobulinemia, 
and neutropenia, with an overall mortality of 4%. 
 
Conclusions 
Our patient began four weekly infusions following the lymphoma protocol. The first 
successfully treated patient achieved complete clinical/serological remission and remained 
symptom-free up to 18 months. We anticipate a similar result for our patient. Additional research 
is needed to include Rituximab within the treatment algorithm for DH.  
 Acquired Methemoglobinenia and Sulfahemoglobinemia  
Secondary to Topical Lidocaine Use 
Brandon Carlisle, M.D., Laura Thomas, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Methemoglobinemia and sulfahemoglobinemia are hemoglobinopathies which result in 
hypoxia from decreased oxygen binding due to iron oxidation. Medications commonly cause 
acquired methemoglobinemia and sulfahemoglobinemia. In this case, we present a 75-year-old 
male admitted to the medical intensive care unit (MICU) for hypoxemia of unknown etiology. 
The unique aspects of this case seem like it was a topical medication that caused this instead of 
oral medications.  
 
Case Presentation 
A 75-year-old with a history of coronary artery disease, end-stage renal disease requiring 
hemodialysis, presented from an outpatient urological procedure with acute hypoxic respiratory 
failure. On admission, he was oxygenating at 83% on room air and required 10 liters of oxygen 
via facemask despite being asymptomatic during this period. His exam was notable for perioral 
cyanosis and oxygenation improved when pressure was applied to his AV fistula. Initial 
laboratory work showed normocytic anemia, no electrolyte abnormalities or anion gap, BNP of 
84, and negative troponins. Of note, his admission ABG showed a pH of 7.45, CO2 of 39, PaO2 
of 186, and Bicarb of 27. He had imaging that was obtained that was unremarkable. Throughout 
his admission, he had low saturations on the pulse oximeter, but always had high PaO2 levels. 
An initial methemoglobin was negative. Initially, isosorbide mononitrate was thought to be the 
causative agent due to an elevated methemoglobin level, but the patient remained hypoxic at his 
follow-up appointment after discontinuation. His outpatient PFT’s were unremarkable. A 
sulfahemoglobin and repeat methemoglobin levels were checked at his outpatient follow-up, 
which resulted in 3% and 2%, respectively. Medications were reassessed. The patient remarked 
that he applies lidocaine jelly on his AV fistula on days he receives dialysis, leading to the 
diagnosis. 
 
Conclusions 
Methemoglobin and sulfahemoglobin cause hypoxia by oxidation of iron in heme preventing 
oxygen binding. If a patient presents with a low SpO2 and a High PaO2, consider obtaining a 
methemoglobin level and sulfahemoglobin level. These causative medications include 
sulfonamides, dapsone, nitrates, benzocaine, or lidocaine. Patients typically have symptoms with 
methemoglobin since it shifts the oxygen dissociation curve left and patients with 
sulfahemoglobinemia typically have no symptoms since the oxygen dissociation curve moves to 
the right. After the diagnosis has been made, removing the offending agent typically resolves the 
hemoglobinopathy. If the patient is symptomatic and has Meth-Hb above 20%, methylene blue is 
indicated. There is no specific treatment for sulfahemoglobinemia except removal of the 
offending agent and close monitoring. Although methemoglobinemia and sulfahemoglobinemia 
are rare side effects of topical lidocaine, clinicians should suspect this in a patient with resistant 
hypoxia.  
 Clinical Relationship between CVID and Inflammatory Arthritis 
Reid Eggleston, Megan Krause, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Common variable immune deficiency (CVID) is the most widespread form of primary 
immune deficiency. Diagnostically, CVID is marked by low serum IgG levels (<400 mg/dL) as 
well as concurrent IgA and/or IgM deficiency. Meanwhile, it has been reported that patients with 
CVID have higher incidence of autoimmune conditions. The objective of this project was to 
assess the impact of arthritis in a cohort of patients with CVID and to assess the pattern of 
arthritis involvement.  
 
Methods 
A retrospective chart review was performed at University of Kansas Medical Center. All 
individuals above the age of 18 between 1/1/2007-12/31/2016 with CVID and selective antibody 
deficiency with normal immunoglobulins (SADNI) were identified first by billing diagnosis then 
confirmed by chart review as determined by the treating immunologist. The chart was reviewed 
for rheumatologic evaluation for history of joint symptoms and data regarding arthritis including 
clinical assessment, laboratory testing, and radiographic results. Treatment strategies utilized for 
joint pain indication were recorded. 
 
Results 
One hundred, seventy patients were identified in the cohort with CVID and SADNI. In this 
cohort, 31 (18%) had an additional rheumatologic diagnosis and 19 (11%) patients had comorbid 
inflammatory arthritis confirmed by a rheumatologist. In the patient population investigated, the 
average age at CVID diagnosis was 48. One hundred, twenty (71%) of these patients were 
female and 163 (96%) were white. Of the 31 patients with a rheumatologic diagnosis, 10 had 
Sjögren’s syndrome, six had rheumatoid arthritis, three had psoriatic arthritis, and three had 
systemic lupus erythematosus. Small joints of the hands tended to be the most commonly 
affected joint regardless of rheumatologic diagnosis with 14 patients having inflammatory PIP 
joint pain and 13 patients having inflammatory MCP joint pain. Other common sites of joint pain 
included the shoulder, knee, and wrist. Nine of the 19 patients (47%) identified with 
inflammatory joint pain were found to have erosive disease radiologically. Treatment of joint 
pain consisted of both traditional DMARD therapy and even newer-line monoclonal antibody 
regimens. Eighty-five percent of patients were treated with hydroxychloroquine and 50% were 
treated by TNF inhibitors.  
 
Conclusions 
Understanding the clinical pattern of arthritis that individuals with CVID experience will 
help inform future study and treatment strategies for clinicians.  
 Long-Term Use of Dual Antiplatelets for the Secondary Prevention  
of Atherothrombotic Events in Patients with and without MI: 
 Meta-Analysis of Randomized Controlled Trials 
Sumaya Hammami, M.D., Amratash Malodiya, Ph.D., Sandra Weiss, M.D.,  
Paul Kolm, Ph.D., William Weintraub, M.D., Zaher Fanari, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
The potential benefit of long-term dual antiplatelet therapy (DAPT) for secondary prevention 
of atherothrombotic events is unclear. Data from different randomized controlled trials (RCT) 
using different agents in different subgroups showed inconsistent results. The goal of this study 
was to evaluate the efficacy and safety of long term DAPT for secondary prevention in patients 
with coronary artery disease with and without prior myocardial infarction (MI).  
 
Methods 
We performed a systematic review and meta-analysis from seven RCTs that tested different 
prolonged durations of DAPT for secondary prevention. Long term DAPT arm was defined as 
those receiving DAPT for more than 12 months. The long-term aspirin arm was defined as those 
receiving either long-term aspirin monotherapy or DAPT for six months or less.  
 
Results 
The use of long term DAPT was associated with a significant decrease in composite of death, 
MI, and stroke (6.08% vs. 6.71%; Odds Ratio OR=0.86 [0.78-0.94]; P=0.001). The reduction 
was mainly driven by a reduction in MI (2.77% vs. 3.16%; OR=0.75 [0.58-0.96]; P=0.03), but 
not in death, cardiac death, or stroke. This reduction of death, MI, and stroke was mainly noticed 
in patients with prior MI (6.32% vs. 7.28%; OR=0.86 [0.79-0.94]; P <0.001). The reduction was 
not seen in patients who underwent drug-eluting stent with no prior MI (4.66% vs. 5.03%; 
OR=0.87 [0.80-0.94]; P=0.38). The reduction in death, MI, and stroke was prominent with 
prasugrel (3.10% vs. 5.90%; OR=0.53 [0.37-0.74]; P<0.001) and ticagrelor (6.95% vs. 5.72%; 
OR=0.84 [0.75-0.93]; P=0.001). Long-term use of DAPT was associated with significant 
increase in major bleeding (1.47% vs. 0.88%; OR=1.65 [1.23-2.21]; P=0.001). 
 
Conclusions 
Long-term use of DAPT for secondary prevention is associated with lower risk of death, MI, 
and stroke, and beneficial in patients with prior MI, but it is associated with increased risk of 
bleeding. This reduction is not seen in post PCI patients with no prior MI. Prolonging DAPT 
requires careful assessment of the trade-off between ischemic and bleeding complications and 
should probably be reserved for patients with higher risk for atherothrombotic events.  
 VT Storm after Anti-Diarrheal Agent 
Jihad Al-Khatib, Shravani Vindhyal, M.D., V. Subbarao Boppana, M.D.,  
Mohinder Vindhyal, M.D., M.Ed. 
KU School of Medicine-Wichita 
 
Introduction 
Loperamide is an effective anti-diarrheal agent which is available over the counter. 
Loperamide is a synthetic opiate acing on mu-opiate receptors in the gastrointestinal tract to slow 
intestinal peristalsis and increase rectal tone. Loperamide does not cross the blood-brain barrier 
at therapeutic doses, hence it does not cause central nervous system effects such as euphoria 
similar to opiates. We report a case of recurrent ventricular tachycardia (VT) storm in a patient 
taking large recreational doses of loperamide. 
 
Case Presentation 
A 45-year-old female patient presented to the hospital after multiple episodes of dizziness, 
shortness of breath, and palpitations. Vital signs revealed a heart rate of more than 200 beats per 
minute and blood pressure was unrecordable. The rest of the physical examination was normal. 
Thorough history from the patient revealed opioid addiction and use of loperamide at 400 mg per 
day (maximum dose is 16mg/day). A 12-lead EKG demonstrated polymorphic ventricular 
tachycardia with a heart rate of 220 beats per minute. The patient was started on amiodarone and 
lidocaine drips, externally defibrillated 16 times, and underwent emergent cardiac catheterization 
which showed normal coronary arteries. She remained conscious through most of the VT storm. 
Transthoracic echocardiogram showed normal ejection fraction and no valvular abnormality. A 
temporary venous pacemaker was placed for ventricular tachycardia pacing and a heart rate of 
100 beats per minute was achieved. Serum electrolytes and urine toxicology screen were normal. 
Cardiac MRI did not reveal any abnormality. Eventually, a temporary pacer was removed 
successfully, and the patient subsequently remained in sinus rhythm with normal QT interval 
without antiarrhythmic agents. 
 
Conclusions 
VT is a potentially fatal arrhythmia and is usually a manifestation of a serious heart condition 
such as ischemia, cardiomyopathy, myocarditis, or structural heart disease. Repeated VT 
episodes requiring cardioversion/defibrillation or appropriate implantable cardioverter 
defibrillator therapy are referred to as VT storm. Loperamide is known to interact with opiate 
receptors in the intestine and slows down peristalsis. Loperamide lacks the typical euphoric 
opiate effects when administered at recommended doses; euphoric effects can be elicited at 
higher-than-recommended doses. Loperamide acts on L-type calcium and potassium channels. 
Blocking of the sodium and potassium channels causes an increase in action potential duration 
resulting in prolonged QT and increased QRS duration leading to polymorphic VT. The 
uniqueness of our case is that our patient not only experienced one episode of VT but also had 
sustained and recurrent polymorphic VT with loperamide. Abrupt resolution of the VT, 
normalization of QT, and lack of the need for an anti-arrhythmic after discontinuation of 
loperamide in our patient makes us believe a causal relationship, but the pathogenesis remains 
unclear.  
 A Case of Red Herrings: Invasive Fungal Sinusitis 
Kristen Constance, M.D., Nicholas Ojile, M.D., Brent Duran, D.O., Shelley Jones, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Acute invasive fungal sinusitis (AIFS) is an aggressive and often fatal condition 
characterized by involvement of the paranasal sinuses with local extension to vital organs. It is a 
rare condition but should be suspected in a patient with immunocompromised status, recent 
surgical intervention, or uncontrolled diabetes mellitus. 
 
Case Presentation 
A 63-year-old Hispanic male with uncontrolled diabetes mellitus 2 was admitted for right 
facial droop. He had been admitted eight days prior for acute vision loss of the right eye 
attributed to central retinal artery occlusion and a third cranial nerve palsy. A CT of the head at 
that time was negative for hemorrhagic stroke and MRI of the brain was normal. He was started 
on high dose steroids for concern of temporal arteritis and biopsy was taken (biopsy later found 
to be negative).  
On readmission, the patient had a severely elevated blood glucose at 700 mg/dL with a white 
blood cell count of 30 x 103/uL; however, he was afebrile and the leukocytosis was initially 
attributed to steroids. Neurological exam revealed multiple cranial nerve palsies of the right 3rd, 
5th, 7th, and 12th nerves. MRI showed sphenoid sinusitis and no evidence for acute ischemia; 
MRV was negative. Cerebrospinal fluid analysis was unremarkable, and fluid culture and gram 
stain were negative. The patient was started on broad spectrum antibiotics as well as 
antiviral/antifungal therapy with acyclovir and amphotericin B. Facial palsies progressed to 
involve the right 2nd and 9th nerves. Infectious disease was consulted for sinusitis on day four of 
admission. The patient’s hard palate was black. Repeat MRI showed infarction of intraocular 
muscles and necrosis of the posterior nasal turbinates. Urgent biopsy by ENT confirmed invasive 
fungal disease, and the patient was immediately transferred to university level hospital for 
emergent surgery. Family opted for comfort care at this facility, and the patient died.  
 
Conclusions 
This case illustrated the high mortality rate associated with AIFS, and the importance of 
maintaining a high degree of clinical suspicion for diagnosis. Although this patient had multiple 
confounders in his case (central retinal artery occlusion, steroids masking a possible 
immunologic reaction), he represented a highly at-risk patient population. Early recognition of 
AIFS with immediate initiation of antifungal treatment and surgical intervention is critical for 
improved prognosis in this highly fatal condition.  
 A Nearly Deadly Skin Lesion: Subcutaneous Rhizopus Murcor in a New Diabetic 
Carley Trentman, Jesse Richards, D.O., Melissa Taylor, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Mucormycosis are fungi ubiquitously found in soil and rotting vegetation. These fungi 
release spores into the air, a common contamination in clinical laboratories. Mucormycosis 
infections typically occur in patients with hematologic malignancy or diabetes. The prevalence 
of mucormycosis varies significantly, from an estimated 0.014% of diabetics in India, to 1/80th 
of that in other developed countries. Rhizopus, a species of mucormycosis, is a deadly infection 
with mortality rates approaching 100% if disseminated or persistent neutropenia is present. 
Generally, sinus is the most common presentation with cutaneous involvement being rare. Here, 
we examine cutaneous mucormycosis in a man who presented in a hyperosmolar hyperglycemic 
state found to subsequently have diabetes.  
 
Case Presentation 
A 63-year-old Caucasian man with a history of basal and squamous cell carcinoma presented 
with a 5-cm wide necrotic lesion on the back of his neck. The lesion was present for several 
weeks, blackening two days before admission. The patient denied trauma to the area but was 
found to have poor living conditions. In the last four months, the patient lost 45 pounds with 
accompanying polydipsia, polyuria, and bilateral paresthesias over his toes. He reported a history 
of anxiety and depression and self-medicated with daily marijuana and 2-ppd of tobacco. Upon 
presentation, his glucose was markedly elevated (1,015); his A1C was >18.5%. CT revealed a 
density collection inferior to the occiput extending to the subcutaneous tissues. A pathology 
specimen was obtained. The patient was diagnosed with hyperosmolar nonketotic hyperglycemia 
secondary to newly diagnosed type II diabetes and started on insulin therapy. Vancomycin and 
Zosyn were initiated while culture and gram stain results pended. His diabetes remained 
controlled after admission. The culture returned positive for Rhizopus species consistent with 
mucormycosis. The patient was sent for surgical debridement. IV amphotericin B and IV 
isavuconazonium were initiated and a wound vacuum was placed. Once stable, he was 
discharged on four weeks of oral posaconazole. 
  
Conclusions 
While cutaneous mucormycosis is rare in immunocompetent hosts, this case illustrates when 
cutaneous involvement in a previously unknown diabetic was diagnosed and treated. Cutaneous 
involvement of Rhizopus is a recent discovery, with the first case reported from an ulcer in 2005. 
In general, the skin barrier represents a host defense against cutaneous mucormycosis, and the 
agents responsible are typically incapable of penetrating intact skin. Typically, traumatic 
disruption of the skin such as burns, maceration of the skin, introduction of contaminated soil, or 
surgical dressings/adhesives are the source. However, this patient denied any trauma to the area 
which illustrates a very atypical presentation. Overall, this patient’s clinical course improved 
markedly. This case demonstrates the importance of early intervention of debridement of 
necrotic Rhizopus infection and glycemic control.  
 The Effect of Pembrolizumab in Absence of Programmed Death 1 Receptor 
Layth Al Attar, M.D., Phu Truong, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Tumor therapy has evolved greatly since the discovery of immunotherapies. New therapies 
permit a targeted approach with less side effects. Immunotherapies target specific components 
recognized on tumor cells, such as Programmed Death-1 (PD-1). Overexpression of PD-1 
markers in solid gastrointestinal tumors is a consequence of deficiency in DNA mismatch repair 
mechanism. Pembrolizumab is an example of immunotherapy targeting PD-1. Pembrolizumab 
binding of PD-1 helps the immune system recognize tumor cells and initiate destruction cascade. 
We present a case of a PD-1 negative appendiceal tumor responding to pembrolizumab. 
 
Case Presentation 
A 63-year-old female presented in 2012 for increased abdominal girth associated with 
nausea, vomiting, constipation, and unintentional weight loss of 10 pounds. The patient was 
diagnosed with primary appendiceal adenocarcinoma based on pathology evaluation post-
surgical resection of an abdominal mass. Genetic testing revealed a negative result for KRAS of 
wild-type, absence of microsatellite instability, and negative PDL-1 testing. The patient received 
different regimens of chemotherapy to manage the initial tumor and recurrence but failed due to 
side effects. She was started on pembrolizumab, although tested negative for PDL-1. After the 
first dose, she reported resolution of her abdominal pain and experiencing regular bowel 
movements. CEA was 95 ng/mL 10 days after the first dose. The test was repeated monthly to 
monitor pembrolizumab benefit. Results showed a downward trend to 80 then 43 ng/mL. CT 
scan was repeated two months after initiation of pembrolizumab. It showed an enlargement from 
previous left supraclavicular adenopathy, stable retroperitoneal periaortic lymphadenopathy, and 
decreased size of hepatic metastasis. The patient continued on this medication with notable 
clinical improvement. She completed 10 doses over a period of six months. A repeat CT scan 
showed increased calcification in relatively similar left supraclavicular lymphadenopathy and 
retroperitoneal adenopathy. Hepatic metastasis lesion was similar in size from previous scans. A 
more recent CEA test showed CEA dropping to 1.9 ng/mL. 
 
Conclusions 
To the best of our knowledge, this is the first report of a gastrointestinal tumor that is PDL-1 
negative and without microsatellite instability showing impressive response to pembrolizumab. 
This case revealed a potential benefit of pembrolizumab. In normal conditions, the PD-1/PD-L1 
pathway downregulates the immune response. Activation of this immune checkpoint inhibitor 
pathway by tumor cells allows for their evasion of an antigen-specific T-cell immunologic 
response. PD-L1 overexpression has been correlated with deficiency in DNA mismatch repair. 
Mismatch repair is a cellular defense mechanism that recognizes and repairs mismatch of bases 
during DNA replication and recombination. POLE gene mutation and tumor mutational burden 
are suggested additional tests to MSI testing aiming to improve patient selection.  
 An Often Unthought of Cause for High-Output Heart Failure 
William Goodman, M.D., Mona B. Brake, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
High-output heart failure is an uncommon cause of heart failure (HF). High-output HF 
patients present with tachycardia, wide pulse pressure, hyperkinetic precordium, and jugular vein 
distention (JVD). A relatively infrequent, and less often thought of cause of high-output HF, is 
an AV-fistula (AVF) used for hemodialysis and is more common in upper arm fistulas as 
compared to forearm fistulas, and is usually seen when the blood flow exceeds 2 L/min.  
There is increasing evidence to support AVF associated heart failure. A cohort study looked at 
the incidence and main determinants of CHF in patients with stage 4-5 pre-dialysis CKD and 
found patients with mainly upper arm fistulas had a 9.5 times greater risk of developing acute 
decompensated CHF (OR=9.54, P<0.0001). A retrospective study found that 25.7% of patients 
with AVF post kidney transplant required fistula closure due to symptoms associated with high-
output cardiac failure.  
 
Case Presentation 
A 53-year-old male presented with a past medical history of diabetes, hypertension, and a 
renal transplant 18 years ago for obstructive uropathy. He developed end stage renal disease due 
to transplant nephropathy and had a brachial artery to cephalic vein fistula created three years 
ago and was started on hemodialysis a few months after AVF creation. In the summer of 2017, 
he received his second kidney transplant. In May 2018, he presented to the emergency 
department with complaint of shortness of air, sharp left upper quadrant abdominal and left-sided 
chest pain of two days duration. Echocardiogram, troponin, and lipase were negative. Computed 
tomography of the abdomen showed no acute abnormalities. Chest x-ray revealed cardiomegaly 
and pulmonary venous congestion with a small left sided pleural effusion. Lab was significant 
for a slightly elevated BNP of 180 pg/mL. He was tachycardic (pulse 100) and tachypneic (rate 
26). He had a grade 5/6 pistol shot systolic murmur best heard at apex. No JVD or edema were 
noted. Echocardiogram showed normal left ventricular systolic function with EF 55-60%, dilated 
IVC, and PAP 35 mmHg. Ultrasound of his AVF showed brachial artery flow at 5.3 L/min and 
cephalic vein flow of 4.4 L/min. He was treated with furosemide and had a rapid improvement of 
his symptoms. Chest x-ray done the following day showed resolution of the pulmonary venous 
congestion and the left pleural effusion. He was referred for surgical banding and discharged 
home. 
 
Conclusions 
AVF formation has proven survival advantages in patients starting chronic hemodialysis. 
Upper arm AVFs are more likely to cause high-output HF. Blood flow in AVFs should be 
monitored and banding considered in high-flow fistulas. Ligation of AVF maybe be considered 
in kidney transplant recipients with good graft function. 
  
 Parathyroid Crisis in a Patient with a Benign Parathyroid Adenoma 
Nicholas Ojile, M.D., Georges Elhomsy, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Primary hyperparathyroidism occurs in 0.1-0.3% of the general population with most cases in 
the seventh decade of life. Primary hyperparathyroidism is the result of inappropriately elevated 
parathyroid hormone (PTH) secretion causing hypercalcemia, with underlying pathologies 
including parathyroid adenoma and parathyroid hyperplasia; less than 1% of cases are due to 
parathyroid carcinoma. Patients can present in a parathyroid crisis with significantly elevated 
serum calcium and PTH levels, a rare complication of hyperparathyroidism. 
 
Case Presentation 
A 72-year-old Caucasian female was admitted for hypercalcemia. Family members reported 
that over the past several days the patient had become more confused, lethargic, and weak and 
she fell the day of her admission. Initial laboratory evaluation showed serum calcium of 14.7 
mg/dl (normal 8.5-10.1 mg/dl) and phosphorus of 2.5 mg/dl (normal 2.5-4.9 mg/dl). A serum 
intact PTH was 1351 pg/ml (normal 14-85 pg/ml). Her renal function was normal. The patient 
was volume resuscitated with crystalloid fluid and subsequently treated with intravenous 
furosemide. She was also given 4 mg of zoledronic acid. A Sestamibi scan was suggestive of a 
parathyroid adenoma, and her serum calcium normalized prior to parathyroidectomy. A right 
inferior parathyroid gland mass was resected and was consistent with a parathyroid adenoma on 
pathology. The first fragment measured 4 x 2 x 1.3 cm and had a mass of 3.175 g; the second 
measured 3 x 1.4 x 0.9 cm with a mass of 1.286 g. Postoperatively, the patient developed 
hypocalcemia and required calcium supplementation.  
 
Conclusions 
Parathyroid crisis is a rare complication of primary hyperparathyroidism, occurring in 1.6% 
to 6% of primary hyperparathyroidism cases. Patients usually present with markedly elevated 
PTH levels and a calcium greater than 14 mg/dl and symptoms of hypercalcemia. The laboratory 
evaluation in a patient presenting with hyperparathyroid crisis from an adenoma can be confused 
with parathyroid malignancy as both can present with markedly elevated PTH. These patients are 
at high risk for multi-organ decompensation due to the severe hypercalcemia including oliguria, 
coma, and cardiac arrhythmias or even cardiac arrest if the calcium levels are not decreased prior 
to surgery with fluid resuscitation and loop diuretics. Parathyroidectomy is the definitive 
treatment for parathyroid crisis.  
 Takotsubo Cardiomyopathy Leading to Left Ventricular Free Wall Rupture 
John Fritzlen, M.D., Tarun Dalia, MBBS, Bashar Amr, M.D., Jared Kvapil, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Takotsubo cardiomyopathy (TTC) is a rare but recognized cardiomyopathy presenting 
typically in post-menopausal women. The prevalence of TTC was reported in 0.02% of 
nationwide hospitalizations with an annual recurrence rate of 1.5% and an inpatient mortality 
rate of 4.5%. While TTC is usually reversible and resolves without complication, it may present 
with systemic embolism, life threatening arrhythmias, left ventricular outflow obstruction, and 
cardiogenic shock. We present an exceptional case of TTC leading to left ventricular wall 
rupture. To the best of our knowledge, only 19 cases have been reported so far showing this very 
rare outcome. 
 
Case Presentation 
A 75-year-old woman with past medical history of coronary artery disease, atrial fibrillation, 
hypertension, hyperlipidemia, and systemic lupus erythematosus initially presented to her local 
emergency department with dyspnea and chest pain. Upon evaluation in the emergency 
department, her systolic blood pressure was 230 mmHg and troponin was 0.26 ng/mL. She was 
transferred to our hospital for management of non-ST-segment elevation myocardial infarction 
(NSTEMI). Transthoracic echocardiogram revealed severe basal hypertrophy, moderately 
reduced ejection fraction, and Takotsubo appearance of the left ventricle involving the mid to 
apical portions. Repeat troponin was elevated at 6.83 ng/mL. The cardiac catheterization lab was 
activated immediately. En route, she became unresponsive and went into ventricular tachycardia. 
ACLS protocol was initiated. She was profoundly hypotensive and had a significant drop in 
hemoglobin from 14.2 mg/dL to 6.1 mg/dL. Resuscitation efforts were performed for 
approximately 50 minutes but were ultimately unsuccessful. Although angiography was unable 
to be performed, autopsy revealed blood in the left chest cavity, grossly patent coronary arteries, 
and a slit-like rupture approximately 1.0 cm x 0.8 cm along the anterior wall at 1.5 cm from the 
base of the heart with large areas of infarction in the left ventricle. 
 
Conclusions 
The criteria for the diagnosis of TTC include transient left ventricular systolic dysfunction, 
elevation of cardiac troponin, and electrocardiographic abnormalities in the absence of coronary 
obstruction. In this case, the echocardiogram findings were suggestive of TTC and autopsy 
showed non-obstructive coronary arteries confirming the diagnosis. The pathogenesis of TTC is 
incompletely understood but thought to be caused by a catecholamine surge often related to a 
physical or emotional stressor. Characteristics of patients with cardiac rupture in TCC include 
female gender, older age group, higher systolic and diastolic blood pressure, greater frequency of 
ST elevations in inferior leads, low ejection fraction, and higher left ventricular peak systolic 
pressure. Though the wall motion abnormalities in TTC typically resolve in days to weeks from 
onset, as described in our case, it can become a life-threatening condition in the acute phase. 
Hence, we recommend close monitoring of TTC patients for the first few days.  
 Extensive Deep Venous Thrombosis in a 31-Year-Old Female on Oral Contraceptives 
Diagnosed with May-Thurner Syndrome 
Erik Calderon, M.D., Brent Duran, D.O., Stephanie Pankow, D.O. 
 
Introduction 
May-Thurner Syndrome is a rare but important diagnosis in a small percentage of new deep 
venous thrombosis diagnoses. The prevalence is unknown but approximated to be 2-5% of the 
causes of symptomatic deep venous thromboses. Risk factors include female gender, post-
partum, and oral contraceptives. It is essential that providers are aware of the high rate of 
recurrence in patients with this diagnosis and act to decrease other modifiable risk factors such as 
oral contraceptives. 
 
Case Presentation 
A 31-year-old female, who was three months post-partum following a C-section, presented to 
the hospital with left lower extremity pain and swelling of one-day duration. She had started oral 
contraceptives three weeks prior to presentation. On physical exam, she had left lower extremity 
edema and palpable dorsalis pedis pulses. There was no warmth or tenderness to palpation. 
Ultrasound showed extensive thrombus throughout the left lower extremity venous system 
involving the popliteal to the common femoral veins with extension into the external iliac vein. 
There was no personal or family history of hypercoagulability. She was given a dose of 
therapeutic enoxaparin at that time and admitted for further management. A heparin drip was 
initiated while bridging to warfarin. Due to the extensive nature of her thrombus, she received 
catheter-directed TPA treatment to her left lower extremity and was found to have a chronically 
occluded inferior vena cava with a large clot burden. At that time, she was diagnosed with May-
Thurner Syndrome. The patient decided to leave before bridging was complete. She left the 
hospital on therapeutic enoxaparin with arrangements to have outpatient stent placement 
performed by interventional radiology. Upon discharge, the oral contraceptives were 
discontinued and lower extremity stockings were placed. She likely will require long-term 
anticoagulation to prevent any further thrombus formations. 
 
Conclusions 
May-Thurner Syndrome, also known as iliac vein compression syndrome, is an extrinsic 
venous compression by the arterial system against bony structures in the iliocaval venous 
territory. The most common variant occurs when the left iliac vein is compressed between the 
right common iliac artery and the L5 vertebrae. Many times, a patient will be asymptomatic 
when there is only a partial obstruction, but it can progress to more symptomatic extensive deep 
vein thrombosis as was seen in this patient. Although uncommon, it is important to differentiate 
May-Thurner Syndrome as a cause of deep venous thrombosis as the treatment modalities and 
long term anticoagulation may differ.  
 Not Your Usual Suspect: A Case of Pill-Induced Esophagitis Caused by Demeclocycline 
Gong Weng, M.D., Matthew Swan, M.D., John A. Bonino, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Pill-induced esophagitis is a well-recognized phenomenon. Most commonly reported cases 
are linked to tetracycline and its variant doxycycline. This case is unique in that demeclocycline, 
a semi-synthetic tetracycline derivative, is the causative agent. In a search of FDA adverse event 
reporting system and WHO adverse drug reactions database, only one similar case of esophagitis 
attributable to demeclocycline was found. 
 
Case Presentation 
A 59-year-old Caucasian woman presented to outpatient endoscopy lab for evaluation of 
odynophagia. She had a medical history of small cell lung cancer (SCLC) complicated by 
syndrome of inappropriate anti-diuretic hormone secretion (SIADH). This was being managed 
with demeclocycline. The patient was a former smoker and denied alcohol and NSAID use. Her 
physical exam was without notable abnormalities. On endoscopic evaluation, the patient was 
found to have a circumferential, ulcerated, necrotic, and fungating mass approximately 17 
centimeters from the incisors. This appearance was suspicious for malignancy, and biopsies were 
obtained. Microscopic examination of the specimen demonstrated fibrinopurulent exudate and 
abundant foreign material, but no malignant cells. The patient was admitted to the oncology 
service for further evaluation, and underwent PEG placement for nutritional support. Given the 
high suspicion for underlying malignant etiology of the esophageal lesion, two subsequent EGDs 
were performed. Both sets of subsequent biopsies were also negative for malignancy. Upon 
review of the patient’s medications, it was felt that patient was likely suffering from pill-induced 
esophagitis related to demeclocycline. Her demeclocycline was stopped, and the patient was 
started on a proton-pump inhibitor. Due to severe hyponatremia, a decision was made to restart 
the demeclocycline but to administer via her PEG tube. On subsequent follow-up in clinic, she 
reported complete resolution of her odynophagia. Due to her overall prognosis, in the setting of 
advanced lung cancer and other comorbidities, a repeat elective EGD was not scheduled. 
 
Conclusions 
This patient presented with a common complaint of odynophagia. Her presentation was 
obscured by a history of SCLC overshadowing a less frequently associated cause of pill-induced 
esophagitis, demeclocycline. Earlier recognition of demeclocycline’s association with pill-
induced esophagitis may have negated the need for multiple repeat endoscopies in the presence 
of non-diagnostic biopsy results. This case highlights the need to consider pill-induced 
esophagitis in the differential of individuals using demeclocyline who present with esophageal 
symptoms.  
 A Case of Intraparenchymal, Intraventricular, Subdural, and Subarachnoid Hemorrhage 
Following Catheter-Directed tPA for Extensive Iliac Deep Venous Thrombosis 
Maha Mohamad, M.D., Rami H. Diab, M.D., John Peterson, D.O.,  
Surayakumar Reddy, M.D., Nazih Moufarrij, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Untreated lower extremity deep venous thrombosis (DVT) may progress to post-traumatic 
syndrome, pulmonary emboli, and death. Anticoagulation remains the hallmark of treatment, 
however, thrombolysis is deemed appropriate in patients with massive proximal DVT with low 
risk of bleeding and good functional status. Importantly, the use of low dose tPA with catheter-
directed therapy as compared to higher dose tPA with systemic therapy has not been shown to 
reduce bleeding complications. As of yet, there remains no clinically validated tool to estimate 
the risk of bleeding in patients with DVT receiving catheter-directed thrombolysis.  
 
Case Presentation 
A 64-year-old female with atrial fibrillation (not previously anticoagulated), fibromyalgia, 
and osteoarthritis was admitted with severe left lower extremity pain of a few days duration. 
Lower extremity ultrasound revealed extensive veno-occlusive disease and confirmatory 
venography demonstrated filling defect extending from the mid-left external iliac vein into the 
entirety of the common iliac vein. Catheter-directed tPA was offered by interventional radiology. 
The patient’s HAS-BLED score was 2 (hypertension, age > 65). An infusion catheter was placed 
in the iliac vein, primed with 4 mg of tPA and left to instill tPA at 1 mg/hour with heparin 
instilled through the indwelling sheath. 
The following day, the patient complained of a progressive headache. CT head without 
contrast revealed intraparenchymal hemorrhage in the right occipital-temporal region measuring 
2.0 x 1.0 cm with subdural and subarachnoid hemorrhage overlying the parasagittal frontal lobes. 
The patient was started on Gabapentin for headache, hypertonic saline for cytotoxic brain edema, 
and physical therapy for deconditioning. Neurosurgery recommended medical therapy. The 
patient’s headache acutely worsened the following day prompting another CT head showing an 
increase in size and density of both temporal-occipital lobe and left frontal lobe hemorrhages 
now measuring 3 x 6 cm and 1.6 x 2.6 cm respectively, each with focal mass effect. A new 
intraventricular hemorrhage also was seen in the dependent portion of the occipital lobes. 
Follow-up CT head showed evolution of intraparenchymal hematomas to 6.5 x 3.2 cm with 
slight worsening of edema and mass effect. The patient gradually improved with tighter blood 
pressure control and physical therapy. Repeat CT head showed reduction in edema of 
parenchymal hematomas and minimal subarachnoid blood, and the patient was discharged to 
inpatient rehab with follow-up. 
 
Conclusions 
Regardless of the dose or route of administration, tPA is associated with bleeding risk even in 
the absence of absolute contraindications. In the absence of a validated bleeding risk assessment 
tool for such scenarios, clinical acumen and a high index of suspicion are quintessential for 
timely management of potentially debilitating bleeding complications should they arise. 
 
 
 
 Association between Electronic Cigarette Use and Coronary Heart Disease and Stroke 
Job Mogire, M.D., Tabitha Muutu, M.D., Paul Ndunda, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
In 2016, 3.2% of US adults and 11.3% of high school students reported using electronic 
cigarettes (e-cigarettes) in the preceding 30 days. Its use among young people increased by 900% 
between 2011 and 2015. Though CHD and stroke are leading causes of death in the US (nearly 
500,000 deaths in 2015), the association between e-cigarette use and coronary heart disease 
(CHD) and stroke remains unknown. This study explores the association between e-cigarette use 
and CHD and stroke. 
 
Methods  
The study is a cross-sectional analysis of the 2016 Behavioral Risk Factor Surveillance 
System (BRFSS), an annual chronic disease risk factor survey conducted by the CDC. The 
sample included 66,795 respondents reporting regular use of e-cigarettes. The control group was 
the 343,856 respondents that reported never using e-cigarettes. Odds ratios were calculated using 
logistic regression analysis. Among the covariates tested, age, sex, smoking status, diabetes, 
exercise, and Body Mass Index (BMI) categories showed significant effects on the model and 
were adjusted for in the outcomes. Since this was a telephone-administered questionnaire, fatal 
events were not included.  
 
Results 
Overall 21% of BRFSS respondents reported ever using e-cigarettes, with 54.7% of the users 
being female (P<0.0001). Compared with non-users, e-cigarette users had a lower mean age (44 
vs 57 years [P<0.0001]), lower mean BMI (27.7 vs 28.1 [P<0.0001]) and a lower rate of diabetes 
(9.8% vs 12.1% [P<0.0001]). They, however, had higher rates of cigarette smoking (78.7% vs 
37.4% [P<0.0001]). Compared with non-users, e-cigarette users had higher odds of myocardial 
infarction (adjusted Odds Ratio [OR] 1.59 [1.53-1.66] P<0.0001), angina or coronary heart 
disease (OR 1.4 [1.35-1.46] P<0.0001), and stroke (OR 1.71 [1.64-1.8] P<0.0001). There was an 
interaction between cigarette smoking and e-cigarette use for all three outcomes (P<0.05). 
 
Conclusions 
E-cigarette use is associated with higher rates of non-fatal myocardial infarction, non-fatal 
angina/coronary heart disease, and non-fatal stroke. However, there is a need for cohort studies 
to establish causation and study fatal events.  
 Blurred Lines:  
HLH Recognition Complicated by Infectious, Neoplastic, and Autoimmune Features 
Clarissa Smith 
KU School of Medicine-Kansas City 
 
Introduction 
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon pathophysiological entity in 
which the body indiscriminately autophagocytoses hematopoietic cells and their precursors 
within tissues such as liver, bone marrow, spleen, and lymph nodes. The Histiocyte Society’s 
diagnostic criteria for HLH is met with five of the following: fever, splenomegaly, two-lineage 
cytopenia, hypertriglyceridemia, hypofibrinogenemia, elevated ferritin, hemophagocytosis, low 
or absent natural killer cells, or elevated CD25. Unfortunately, many cases of HLH are still 
diagnosed at autopsy, due to these vague clinical indicators in combination with the rapidity of 
irreversible hemostasis disruption.  
 
Case Presentation 
A 76-year-old male was admitted in transfer for acute onset mental status changes with 
elevated transaminases, thrombocytopenia, ferritin > 40,000µg/L, and 2/4 Systemic 
Inflammatory Response Syndrome (SIRS) criteria. Past medical and family history were bland, 
but the patient reported incurring recent insect bites while doing yardwork around his rural 
home. Consultations with infectious disease and hematology were requested right away and 
empiric doxycycline for tickborne illness and dexamethasone for HLH was initiated while 
additional testing was performed. An extensive infectious workup was positive only for Epstein 
Barr Virus (EBV) viremia. Due to its known correlation with HLH, Etoposide was started 
according to HLH-2004 recommendations. The patient’s condition continued to decline with 
worsening pancytopenia, a new dialysis requirement, loss of airway protection, and DIC. The 
patient awoke with acute left-sided weakness, and MRI demonstrated multiple scattered infarcts. 
Due to the patient’s continued decline, Etoposide was subsequently discontinued. He then 
developed a pulmonary infiltrate, hypotension, as well as bradycardia, and ultimately died from 
cardiac arrest. Autopsy was performed with family consent and revealed disseminated 
hyalohyphomycosis due to the immunocompromise induced by HLH triggered by EBV viremia.  
 
Conclusions 
While familial forms of HLH have been described, it more frequently arises secondarily to 
states of systemic inflammation such as malignancy, autoimmunity, or infection. Ongoing 
investigations demonstrate positive correlation with the exuberant production of macrophage-
activating cytokines such as interferon-gamma and tumor necrosis factor-alpha. Many diverse 
viral, protozoal, fungal, bacterial, and even plasmodium pathogens and opportunistic infections 
have been implicated in HLH. Of these, EBV is the most common and also has the highest 
lethality rate. Testing for underlying pathogens should be guided by the patient’s medical and 
social history. Despite increased awareness and recognition of the syndrome, 50% of patients die 
due to multi-organ failure or infectious complications. The rarity of this syndrome also limits 
trials to create and improve therapeutic options. Current treatment recommendations are based 
on a combination of immunotherapy and chemotherapy outlined in the HLH-2004 study, but 
early recognition of this condition continues to be the most effective means of decreasing 
associated morbidity and mortality. 
 Percutaneous Repair of Mitral Valve Regurgitation  
Due to Post-Infarction Papillary Muscle Rupture Using Mitraclip Apparatus 
Cyrus Munguti, M.D., Paul Ndunda, M.D., Bassem Chehab, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Post-infarction papillary muscle rupture carries high morbidity and mortality. While surgical 
repair is gold standard, percutaneous repair is now feasible especially in high surgical risk 
patients. We present a case of successful percutaneous repair of mitral valve regurgitation from a 
ruptured papillary muscle. 
 
Case Presentation 
A 66-year-old male patient presented to the emergency department with sudden onset chest 
discomfort and exertional dyspnea. He described a left-sided, dull discomfort accompanied by 
exertional dyspnea. He had had a recent sternotomy and was not very active at baseline. He had a 
past medical history of coronary artery bypass (CABG) for coronary artery disease, open aortic 
valve replacement followed by a trans-femoral aortic valve replacement (TAVR). On 
examination, he had a systolic murmur at the apex radiating to the axilla and bilateral edema on 
the ankles. A transthoracic echocardiogram (TTE) revealed mitral regurgitation that was not 
previously noted. A trans-esophageal echocardiogram (TEE) showed flail anterior leaflet at A1 
segment with torrential mitral regurgitation. He declined a third sternotomy but was agreeable to 
MitraClip repair. He consented to the procedure. 
An intraoperative TEE revealed the papillary muscle at the base of the anterior mitral leaflet 
mainly at the A1 segment, with significant flail and prolapsing leaflet and severe mitral 
regurgitation. Trans-septal puncture was done and then an E-clip sheath was inserted in the left 
atrium and heparin was given per protocol. A first clip was deployed in at the medial part of the 
A1 segment, capturing the base of the papillary muscle in the A2 segment. Then a second clip 
was deployed lateral to the first at the level of A1-P1, decreasing mitral regurgitation to trace 
with a mean gradient of 5 mmHg. The system was removed. Perclose was deployed with 
excellent hemostasis. 
 
Conclusions 
Trans-catheter mitral valve repair using the MitraClip (Abbot) apparatus is mostly done for 
chronic mitral regurgitation due to valve degeneration or functional chronic conditions. 
Percutaneous repair using MitraClip offers benefits to high risk patients including less 
destruction of surrounding tissue associated with surgery, sudden return in pre-morbid cardiac 
output following the repair by reducing the left atrial and ventricular pressures hence increased 
contractility and reversal of cardiogenic shock. Our patient had complex anatomy following open 
aortic valve replacement, TAVR valve in situ, and CABG but still managed to get good valve 
coaptation. A TTE done on the 30-day follow-up showed minimal mitral regurgitation.  
In select cases, percutaneous repair of ruptured papillary muscle is possible and should be 
considered where surgical intervention is not an option.  
 The Problematic Nature of Fibromyalgia Diagnosis in the Community 
Sachin Srinivasan, M.D., Eamon Maloney, M.D., Rami Diab, M.D., Brynn Wright,  
K. James Kallail, Ph.D., Michael Kennedy, M.D., Frederick Wolfe, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Fibromyalgia is a common, if contested diagnosis. A physician’s diagnosis is required for 
access to treatment and disability status. Recently, two studies have suggested that clinical 
diagnosis is inaccurate and does not reflect current scientific definitions, but this hypothesis has 
not been tested formally in the community. We tested whether fibromyalgia was diagnosed 
accurately in the community, whether diagnosis was biased by sex, and examined the effect of 
physician and criteria-based diagnosis on treatment. 
 
Methods 
We surveyed 3276 consecutive adult patients attending one of 26 primary care practices in 
Kansas using a completely de-identified self-report questionnaire that contained the 2016 
modification of the American College of Rheumatology diagnostic criteria to determine current 
fibromyalgia status (CritFM). We also determined by self-report whether the patient had a 
previous or current physician’s diagnosis of fibromyalgia (MDFM), the level of fibromyalgia 
symptom severity as measured by the polysymptomatic distress scale (PSD), time from MDFM 
diagnosis, and the use of current and past FDA approved pharmacotherapy. Questionnaires were 
dispensed and collected prior to physician visits by second year medical students during a 
Summer Training Option in Rural Medicine (STORM).  
 
Results 
The prevalence of physician (MDFM) and criteria (CritFM) diagnosed fibromyalgia in 
primary care was 5.3% (95% CI 4.4%, 6.1%) and 5.5% (95% CI 4.8%, 6.4%), respectively. 
However, only 34.5% with MDFM met fibromyalgia 2016 criteria (CritFM), and only 33.1% 
with CritFM also had MDFM. The kappa statistic for agreement beyond chance between 
physician diagnosis and diagnostic criteria was 0.330 (slight agreement). The mean pattern 
standard deviation score was 13.2 and 18.4 in MDFM and CritFM, and generalized pain was 
present in 42% and 100%, respectively. Diagnostic agreement increased slightly with duration of 
MDFM. The odds ratio for a patient being a women compared to being a man was 4.0 (95% CI 
2.5, 6.2) for MDFM and 1.9 (95% CI 1.4, 2.8) for CritFM, p = 0.004. Current treatment and ever 
treatment was related to MDFM but not to CritFM. Only 4.1% of patients with CritFM but not a 
physician diagnosis ever received the drug treatment. By contrast, 70.7% of patients with a 
MDFM were treated. 
 
Conclusions 
There is little agreement between MDFM and CritFM (kappa= 0.330). Only 1/3 of MDFM 
satisfy fibromyalgia criteria, and only 1/3 of patients who meet criteria have a clinical diagnosis 
of fibromyalgia. Physician diagnosis compared with CritFM is biased and more likely in women. 
Fibromyalgia treatment is rare in CritFM (4.1%), but very common in MDFM (70.7%). Overall 
diagnosis of fibromyalgia by physicians appears idiosyncratic and unrelated to FM criteria. 
There appears to be no common definition of fibromyalgia in the community.  
 A Rare Case of Prekallikrein Deficiency 
Sammy Tayiem, M.D., Abdulraheem Yacoub, M.D.  
KU School of Medicine-Kansas City 
 
 Introduction 
Prekallikrein (PK) deficiency is an extremely rare autosomal recessive disease. First 
described in 1965, PK deficiency was originally discovered in four siblings with an 
asymptomatic and prolonged aPTT. It has since only been reported around 80 times in the 
literature. We hereby report a patient with confirmed PK deficiency.  
 
Case Presentation 
A 41-year-old African-American female without a significant past medical history was 
referred to our Hematology and Oncology clinic due to a prolonged aPTT (100.7 seconds) on her 
pre-operative workup prior to a hepatic hemangioma resection. She denied any personal or 
family history of abnormal bruising, bleeding, or thrombotic phenomena. The patient has had 
two C-sections and a hernia surgery without hemorrhagic complications. Physical exam was 
unremarkable. 
Hematological workup confirmed a prolonged aPTT with full correction on mixing study, 
normal PT/INR, normal thrombin time, normal von Willebrand Factor profile, and normal 
platelet function assay. The patient had normal clotting factor levels including XII, XI, IX, VIII, 
X, V, II, and a normal HMW kininogen. Additional testing confirmed a severe PK deficiency (< 
5%). A confirmatory assay at a reference lab confirmed the results. She underwent the planned 
resection of hepatic hemangioma without special precautions and had no abnormal bleeding. The 
PK deficiency and prolonged aPTT persisted after resection of the hemangioma. 
 
Conclusions 
PK is a single-chain protein that is converted to its active form, kallikrein, by activated factor 
XII. Activated kallikrein may further activate factor XII, promote the activation of the 
fibrinolytic system, and cleave kininogen to release bradykinin. PK deficiency can either be 
inherited or acquired in patients with hepatic disease or disseminated intravascular coagulation. 
The deficiency has been localized to mutations in the KLKB1 gene on chromosome 4. PK 
deficiency has been reported in nearly all races, however, it is seen more frequently in African-
American patients. The true prevalence of PK deficiency is unknown as most affected people are 
usually asymptomatic. PK deficiency can be identified by an isolated prolonged aPTT and 
normal PT, in which the aPTT corrects to normal in mixing studies. It is then finally confirmed 
with a specific PK assay. 
Identification of such a rare deficiency is clinically significant in that a prolonged aPTT will 
repeatedly prompt an extensive workup that may unnecessarily delay treatments or procedures. 
Despite a prolonged aPTT, there is no increased risk of bleeding due to compensation by the 
extrinsic pathway. PK deficiency may, however, be associated with thrombotic phenomena due 
to defective activation of the fibrinolytic system, as well as hypertension secondary to decreased 
bradykinin levels; demonstrating the far-reaching and complicated effects of prekallikrein.  
 A Rare Case of Nonbacterial Thrombotic Endocarditis (NBTE)  
in a Young Patient with Acute Myelogenous Leukemia 
Rami Atallah, M.D., Nicholas Ojile, M.D., Kamal Chamoun, M.D., Fredy Nehme, M.D., 
Mohinder Vindhyal, M.D., M.Ed. 
KU School of Medicine-Wichita 
 
Introduction 
Nonbacterial thrombotic endocarditis (NBTE), formerly known as marantic endocarditis, is a 
rare condition characterized by deposition of sterile thrombi on heart valves with the absence of 
bacterial growth on blood cultures. NBTE is clinically significant as it increases the risk of 
systemic embolic events including stroke. Microscopically, NBTE results from agglutinated 
platelets mixed with strands of fibrin. NBTE is most commonly associated with advanced 
malignancy and various autoimmune conditions. In this report, we present a case of NBTE in a 
26-year-old woman presenting with AML. 
  
Case Presentation 
A 26-year-old female with a history of recurrent pancreatitis presented to her primary care 
physician with abdominal pain, cough, dyspnea, and fatigue. Outpatient lab work showed a 
hemoglobin of 4 g/dl for which she was admitted to our institution for further evaluation. On 
admission, her platelets were 56x10^9/L, WBC 14x10^9/L with 40% peripheral blasts. Bone 
marrow biopsy confirmed the diagnosis of acute myelomonocytic leukemia. The patient was 
then started on induction chemotherapy with daunorubicin and cytarabine. An initial 
transthoracic echocardiogram revealed an ejection fraction of 55% with no valvular 
abnormalities. After starting chemotherapy, the patient’s respiratory status rapidly worsened 
requiring intubation. The patient's blood counts continued to drop requiring multiple blood and 
platelet transfusions. Blood cultures were repeatedly negative. A week after being intubated, the 
patient developed multi-organ failure including brain and kidneys. The patient subsequently 
suffered from left leg ischemia caused by an arterial clot in the deep femoral artery. Family 
discussion led to comfort care decision. Advance supportive care was withdrawn, and the patient 
died soon after. The autopsy revealed fibrin vegetations on the aortic and the tricuspid valve 
consistent with NBTE as well as massive non-hemorrhagic infarct on the left frontal, parietal, 
and the occipital lobes. Multiple infarcts were evident in spleen and both kidneys. Pulmonary 
hemorrhage was also noted. 
  
Conclusions 
NBTE is a rare condition, associated with very high mortality and morbidity rates. It is 
uncommonly reported in patients with acute myeloid leukemia and is often a postmortem 
diagnosis. The most likely cause of death is multiple infarcts seen in the brain and various 
organs. Diagnosis of this condition is always challenging. Physicians should always suspect 
NBTE in patients presenting with multiple infarcts with a history of malignancy or autoimmune 
disease.  
 Leclercia Adecarboxylata in a Post-Fasciotomy Polymicrobial Infection 
Andrew Weaver, M.D., Margaret E. Hagan, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Leclercia adecarboxylata is a rare Gram-negative bacillus that previously belonged to the 
Escherichia genus. It has been implicated in traumatic wounds, nosocomial pneumonias, and 
bloodstream infections including central line-associated bloodstream infections. Some strains 
have shown antibiotic resistance including extended spectrum beta-lactamase. The following 
case demonstrated Leclercia adecarboxylata as part of a lower extremity polymicrobial infection 
that developed in a patient following compartment syndrome, fasciotomy, and surgical 
debridement. 
 
Case Presentation 
A 31-year-old male was admitted for management of a suspected infected fasciotomy wound. 
One month prior, he had sustained a tibia fracture that was surgically repaired; he subsequently 
developed compartment syndrome that necessitated fasciotomy and surgical debridement of 
necrotic muscle. The patient was previously healthy with no chronic medical problems, no home 
medications, no allergies, and a benign family history. Surgical history included back surgery 
and appendectomy in addition to his recent surgeries. He was a daily smoker. Review of systems 
at admission was negative. Vital signs were notable for tachycardia. Physical examination 
revealed a large left leg wound with granulation tissue and an odor. He had mild leukocytosis as 
well as low hemoglobin and serum albumin. Empiric intravenous vancomycin and piperacillin-
tazobactam were initiated. Culture of the wound bed grew pan-susceptible Leclercia 
adecarboxylata, Group G Streptococcus, and Corynebacterium species. Surgical culture from a 
repeat debridement grew Enterobacter cloacae, Enterococcus faecalis, and Candida parapsilosis. 
The infection improved with piperacillin-tazobactam, oral fluconazole, and local vancomycin-
tobramycin beads followed by a prolonged course of intravenous ertapenem and oral fluconazole 
at home. 
 
Conclusions 
Leclercia adecarboxylata is an uncommon but important pathogen in both mono- and 
polymicrobial infections. Clinicians should consider this entity particularly when managing post-
trauma and nosocomial infections.  
 When Empiric is Imperative: Differentiating Encephalopathy from Encephalitis 
Gretchen Beaver, Jesse Richards, D.O., Jessica Newman, D.O. 
KU School of Medicine-Kansas City 
 
Introduction 
A differential diagnosis of altered mental status is expansive, especially when the patient is 
non-English speaking and multiple comorbidities are present. Knowing where to start is 
daunting; determining if the patient has encephalopathy or encephalitis is paramount as a delay 
in antimicrobials is devastating. This case highlights how immediate empiric therapy for 
common causes of encephalitis can have a profound impact on outcome when a history cannot 
be obtained. 
 
Case Presentation 
A 71-year-old, non-English speaking, Southeast Asian woman presented with two-days of 
lethargy and one-day of altered mental status. Her past medical history included metastatic breast 
cancer, systolic and diastolic heart failure, and stage 3 chronic kidney disease. She was 
hospitalized the month prior for pneumonitis with a prednisone taper and remained on 40 mg 
daily. Obtaining medical history was limited. Family accounts noted impaired cognition at 
baseline and deconditioning from the recent hospitalization. She was afebrile and 
hemodynamically stable. On examination, she was lethargic and only responsive to pain. 
Additional pertinent findings included scleral icterus and abdominal distention without fluid 
wave. She had no meningismus or rash. 
A complete blood count was notable for stable chronic pancytopenia. Pertinent lab results 
included a baseline creatinine of 2.04, total bilirubin of 3.9 (increased from 2.2), an 
unremarkable urinalysis, and a normal lactate. Computed tomography of the abdomen/pelvis 
demonstrated a mildly nodular liver, suggestive of cirrhosis and mesenteric congestion. Lumbar 
puncture was delayed due to pending coagulopathy studies and CNS imaging (no acute findings), 
so empiric intravenous ceftriaxone, vancomycin, ampicillin, and acyclovir were initiated. 
Cerebrospinal fluid demonstrated RBC 1400, WBC count of 70 (53% lymphocytes), protein 64, 
and normal glucose. The pleiocytosis confirmed the clinical diagnosis of encephalitis. No 
organisms were seen on gram stain and cultures remained negative. HSV-2 PCR was positive 
with antibiotic therapy de-escalated and prednisone tapered. Within one week of treatment, her 
mental status improved. By week two, she was at baseline per family and stable for discharge.  
 
Conclusions 
While HSV-2 encephalitis was low on the initial differential, failure to promptly initiate 
antimicrobial therapy may have led to irreversible neurologic disability or death. Studies have 
shown that time of onset of medical treatment impacts resultant outcome with treatment 
initiation within 1.8 days correlating to good outcome and 4.0 days correlating to poor outcome.  
HSV-1 encephalitis is generally uncommon (incidence 1.2/100,000) and HSV-2 encephalitis 
even more rare. As treatment with IV acyclovir has decreased mortality from ~70% to ~20%, 
there should be no delay in empiric therapy. If encephalitis is on the differential (especially in 
this patient on prolonged steroid therapy) and lumbar puncture is delayed, consider prompt 
empiric IV antimicrobials including acyclovir. The diagnostic standard, HSV PCR remains 
positive for the first few days of therapy. 
  
 Immunotherapy Induced Myocarditis 
Garret Seiler, D.O., Aarati Keshary, M.D., Jeremy Deutsch, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Tumor cells evade the host immune system by overexpressing PD-1 and CTLA-4 surface 
proteins. Monoclonal antibodies targeting these receptors have revolutionized cancer treatment. 
Combinations of these immunotherapies have received FDA approval as salvage therapy or first 
line therapy in select tumors. Autoimmune inflammatory reactions are well-recognized side 
effects of these medications. The skin, the gastrointestinal system, the thyroid gland, and the 
liver are the most commonly affected organs. Less commonly, the lungs, muscles, or brain may 
be affected. Signs of these side effects merit prompt, high-dose corticosteroids and cessation of 
the offending agent. 
 
Case Presentation 
A 50-year-old female presented to the hospital with shortness of breath and left-sided chest 
pain. She had a past medical history of Stage IV non-small cell lung adenocarcinoma (EGFR, 
ALK, ROS-1 Negative). She had been placed on Ipilimumab and Nivolumab 13 months prior to 
the current visit as part of a clinical trial and had experienced a good response without tumor 
progression or significant side effects. Her current evaluation was significant for an elevated 
troponin of 0.21 ng/mL as well as a new intra-ventricular conduction delay without ST segment 
elevation on EKG. Vitals revealed heart rate of 106 beats per minute, respiratory rate of 17, 
blood pressure of 95/73 mmHg, and oxygen saturation of 100% on room air. AP view chest x-
ray was suspicious for pulmonary edema. Brain natriuretic peptide and creatinine phosphokinase 
were unremarkable. Over 12 hours, her troponin trended up to 2.9 ng/mL. A trans-thoracic 
echocardiogram revealed diffuse akinesis and reduced ejection fraction of 15%. A heart 
catheterization showed no evidence of coronary artery disease. Immunotherapy-induced 
myocarditis was suspected. High dose corticosteroid therapy was initiated. By the fourth day of 
hospitalization, her troponin trended down to normal levels and her symptoms began to abate. 
On hospital day eight, a repeat trans-thoracic echocardiogram showed improvement of her 
ejection fraction to 45%. EKG no longer showed intra-ventricular conduction delay. Serum PCR 
studies for adenovirus, enterovirus, and Epstein-Barr virus were negative. 
 
Conclusions 
Autoimmune inflammatory reactions are well recognized side effects of PD-1, PDL-1, and 
CTLA-4 inhibitors. Increased T-cell activation following the unmasking of the tumor cells to the 
immune system leads to bystander tissue damage. In 2016, two case reports of Ipilimumab and 
Nivolumab induced fulminant myocarditis were described. Both cases resulted in rapid mortality 
despite high-dose corticosteroid therapy. This case of immunotherapy induced myocarditis 
shared similarities but also contained key differences from the previous cases: the timing of 
onset, degree of cardiac injury, and therapeutic response to steroid therapy. As their indications 
increase, myocarditis is increasingly recognized, as well as the deadly side effect of 
immunotherapies. Prompt recognition may improve mortality outcomes.  
 Cutaneous Leishmaniasis 
Thanuja Neerukonda, Ryan Kubat, D.O., Fernando Merino, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Leishmaniasis is a spectrum of diseases caused by species of Leishmania protozoa and 
transmitted by sandfly vectors. The most common clinical manifestation is cutaneous 
leishmaniasis with approximately 0.7-1.2 million new cases per year, primarily in the Middle 
East and Central and South America. We report a case of complicated cutaneous leishmaniasis 
diagnosed in an immigrant from Honduras and a unique treatment with excisional therapy only. 
  
Case Presentation 
A 22-year-old male with no past medical history was referred to the University of Kansas 
Infectious Diseases clinic with a left facial lesion. He first noted a small “pimple” about six 
months prior. The lesion began growing in size and developed some surrounding erythema. He 
was evaluated by a physician and prescribed a course of oral antibiotics without improvement. 
The lesion grew for three months and developed a necrotic center, after which it stopped growing 
and kept the same appearance. It was not associated with any pain or drainage and he did not 
have any fever or systemic symptoms. Examination revealed a 2x3 centimeter left pre-auricular 
skin lesion with well-defined borders and a large central necrotic eschar. There were no mucosal 
lesions or lymphadenopathy. CBC and CMP were normal. Further history revealed the patient 
had emigrated from Honduras three months prior to onset of symptoms. He traveled for two 
weeks, sleeping in the open air, and recalling many insect bites during his trip. He crossed the 
border in Texas and spent three weeks in a detention center in Louisiana prior to moving to 
Kansas City. 
A biopsy obtained by the referring physician revealed abundant intracellular organisms with 
acute and histiocytic inflammation, most consistent with leishmaniasis. After consulting with the 
CDC and plastic surgery, the decision was made to excise the lesion for definitive diagnosis 
along with performing a skin flap for optimal cosmetic outcome. Surgical pathology was again 
consistent with leishmaniasis. A sample was submitted to the CDC for PCR testing and DNA 
sequencing, confirming infection with Leishmania mexicana. Pharmacologic treatment with 
liposomal amphotericin B was attempted, however, he reported chest tightness, dyspnea, and 
flushing within the first minute of infusion. He developed the same symptoms despite pre-
medicating with diphenhydramine and acetaminophen while slowing the infusion rate. Other 
pharmacologic options were discussed, but the patient declined further treatment. He continues 
to be seen for surveillance; he has a hypertrophic scar but no evidence of recurrent infection. 
  
Conclusions 
Recognition and diagnosis of cutaneous leishmaniasis is important for determining disease 
severity and initiating treatment if indicated. Although only a few cases of transmission have 
been reported within the United States in Texas and Oklahoma, it is an emerging infection to be 
aware of in travelers and migrants from endemic areas.  
 From Murmur to Amyloidosis: Stressing the Importance of Physical Exam 
Ethan Hacker, M.D., Branden Comfort, M.D., MPH 
KU School of Medicine-Kansas City 
 
Introduction 
AL amyloid cardiomyopathy is a rare, but serious disease caused by abnormal deposition of 
amyloid protein within the heart leading to heart failure with significant mortality. Here, we 
present a case of cardiac amyloidosis diagnosed after unusual exam findings. 
 
Case Presentation 
A 53-year-old female with past medical history of breast cancer who had undergone 
mastectomy and radiation, depression, hypertension, and chronic pancreatitis presented to her 
primary care physician with complaint of enlarging neck lump over the past two months. This 
had been accompanied by gagging, difficulty with swallowing food, and weight loss of seven 
pounds. She described no history of stridor, but stated that with exertion she became more short 
of breath. On examination, she had an enlarged thyroid gland without nodularity, moderate 
tachycardia, and a 3/6 holosystolic murmur. She also had 1+ pitting edema in her lower 
extremities that had been developing over the same time period as the rest of her symptoms. A 
CT scan of her neck showed a substantially enlarged thyroid with evidence of compression on 
the esophagus. The patient was referred to ENT and plans were made for thyroidectomy. Prior to 
her thyroidectomy, an echocardiogram was obtained for her new systolic murmur which showed 
obstructive hypertrophy with diastolic dysfunction. Her surgery was delayed and she was 
transitioned from a diuretic to a beta blocker in order to avoid decreased preload that could lead 
to further obstructive cardiac physiology. Cardiology referral was placed, and she underwent 
evaluation with cardiac MRI and stress testing. After being cleared by cardiology, she underwent 
thyroidectomy and was found to have significant deposition of amyloid on surgical pathology. 
Her cardiac MRI showed a prominent basal interventricular septum, as well as diffuse infiltration 
of myocardium consistent with amyloid cardiomyopathy. Serum free light chain analysis 
revealed an elevated free lambda light chain, and a significantly decreased kappa/lambda light 
chain ratio. SPEP revealed a monoclonal spike of beta/gamma immunoglobulins. Fat pad biopsy 
confirmed AL amyloidosis on Congo red staining and bone marrow biopsy revealed 5% 
monoclonal plasma cells. The patient was diagnosed with multiple myeloma and initiated on 
cyclophosphamide, bortezomib, and dexamethasone chemotherapy.  
 
Conclusions 
This case highlights the importance of physical exam findings and the heterogeneous array of 
diagnoses possible from relatively common findings. In this case, findings of a murmur and 
goiter led ultimately to diagnoses of multiple myeloma and cardiac AL amyloidosis. Had clinical 
evaluation of her murmur not been undertaken, she would have remained on dangerous pre-load 
depleting diuretic therapy with obstructive cardiomyopathy during surgical resection of her 
thyroid. While her AL amyloid cardiomyopathy caries a poor long term prognosis, early 
recognition and treatment likely led to significantly improved quality and quantity of life.  
 Congenital Renal Arteriovenous Malformation:  
A Rare but Treatable Cause of Hypertension 
Nicholas Isom, M.D., Reza Massomi, M.D., Adam Alli, M.D., Kamal Gupta, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Congenital renal vascular anomalies are rare yet important potential causes of significant 
morbidity. They have been classified into three categories: cirsoid, angiomatous, or aneurysmal. 
These classifications are based on the size, location, and number of vessels involved. This case 
illustrates the diagnosis and unique treatment of this rare etiology of secondary hypertension. 
 
Case Presentation 
A 29-year-old Caucasian female was seen in the hypertension clinic as a referral from the 
high-risk obstetric clinic for management of hypertension (HTN). She was contemplating 
pregnancy. She had been diagnosed with HTN at age 19 and had been on antihypertensive 
medications (was on Methyldopa 500 mg BID) with uncontrolled HTN. She had an extensive 
secondary cause work-up that was reported as normal (ruling out Pheochromocytoma, 
hyperaldosteronism, Cushing’s, and thyroid disorders). Renal artery duplex done elsewhere was 
reported as moderately increased left renal artery peak systolic velocity but normal renal to aortic 
ratio (ARR) not suggestive of renal artery stenosis. Our review of the images showed that the 
peak proximal left renal artery velocity was 225 cm/sec with ARR of 1.3. However, the diastolic 
flow was especially prominent in the proximal left renal artery as compared to the right side and 
color Doppler US image of the left kidney showed a large diameter vascular structure at the 
hilum that had not been interrogated with spectral Doppler. An MRA was done that showed a 
large left renal upper pole arteriovenous malformation (AVM) with associated vascular shunting 
and early opacification of the left renal vein. Since the patient had no history of trauma or 
surgery, this was considered likely to be a congenital AVM. Selective arteriograms identified a 
single origin from the proximal renal artery and this was closed successfully with coil 
embolization. Fortunately, the arterial branch involved was only perfusing a small part of the 
renal parenchyma and thus there was no significant renal injury. The patient’s BP normalized 
within a few days and she came off her antihypertensive medications. At six-month follow-up, 
she remained normotensive off all medications and was discharged from the hypertension and 
high-risk obstetric clinics.  
 
Conclusions 
Aneurysmal malformations, such as this one, have a single (and dilated) feeding and draining 
vessel. The prevalence of renal AVMs is estimated at less than 0.04% making them rare causes 
of secondary hypertension. However, they respond well to embolization with resolution of 
hypertension in 59% of patients treated. This case illustrates that a careful review of duplex 
waveforms beyond just peak velocity and ratios is important to identify uncommon pathology.  
 Chronic Inflammatory Arthropathy in the Setting of Levamisole-Induced Vasculitis 
Kyle Myers, D.O., Pooja Bhadbhade, D.O. 
KU School of Medicine-Kansas City 
 
Introduction 
Levamisole, an anti-helminthic drug, is a common adulterant of cocaine with well-described 
auto-immune phenomena, most notably complications of ANCA-associated vasculitides. Though 
arthralgia is a relatively common symptom of levamisole-induced vasculitis, the specific 
association of levamisole toxicity and inflammatory arthropathy is less well-documented. This 
case describes the incidental findings suggestive of chronic, deforming, erosive arthropathy in 
the setting of a patient with inflammatory eye disease secondary to suspected levamisole-induced 
vasculitis. 
 
Case Presentation 
A 46-year-old woman with remote history of levamisole-induced skin necrosis and chronic 
cocaine use presented with right eye foreign-body sensation, eye pain, redness, and decreased 
vision that began abruptly four days prior to admission. She had associated fever, myalgia, night 
sweats, joint pain, swelling, and stiffness in her hands, elbows, and knees. She had history of 
laboratory-proven levamisole-induced skin necrosis six years prior from cocaine abuse. Her 
exam showed findings suggestive of chronic inflammatory arthropathy and a round ulcerative 
right ankle lesion. Ophthalmologic exam demonstrated anterior uveitis, posterior scleritis, 
dacryoadenitis, and ocular hypertension. Notable admission labs were cocaine on urine drug 
screen, elevated erythrocyte sedimentation rate, and C-reactive protein, positive anti-nuclear 
antibody with a titer of 1:160, positive p-ANCA with a titer of 1:1280, and elevated anti-
myeloperoxidase at 0.7. Notably, WBC count was normal, urinalysis was without hematuria or 
proteinuria, and c-ANCA, PR3, complement 3 and complement 4 as well as complete extractable 
nuclear antigen panel were negative. Infectious workup was negative. Plain films of the hands 
showed findings consistent with inflammatory arthropathy. CT chest was without significant 
findings. Lacrimal gland biopsy demonstrated dacryoadenitis with foci of chronic inflammatory 
cells and biopsy of her right ankle lesion showed non-specific inflammation. She was treated 
with topical eye drops, acetazolamide, anterior chamber tap, and systemic steroids with 
improvement in her ocular symptoms and intraocular pressure. She was extensively counseled on 
stopping cocaine use. 
 
Conclusions 
Her presentation was thought secondary to either levamisole-induced vasculitis or idiopathic 
ANCA-associated vasculitis. Given the pattern of her autoimmune labs and history of 
levamisole-induced skin necrosis, levamisole was favored as the likely etiology of her 
inflammatory eye disease. Levamisole has many known immunological effects, including the 
induction of antibodies against various antigens resulting in a multitude of systemic 
complications. If levamisole can induce such manifestations as necrotic skin lesions, vasculitis, 
glomerulonephritis, and pulmonary hemorrhage, it is possible that over time it could also lead to 
an erosive arthritis, as in this patient. This case documents the possible relationship between 
levamisole and inflammatory arthropathy. Recognizing this correlation would have unique 
implications on treatment and prevention of associated systemic manifestations.  
 Burning Fat 24/7: Dangers of the Ketogenic Diet When Taking a SGLT-2 Inhibitor 
Sukhindervir Sandhu, Jesse Richards, D.O., Candice Rose, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
There are several pharmacologic treatments available to treat type 2 diabetes mellitus 
(T2DM). Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are one of the commonly 
indicated medications because of their weight loss, cardiovascular benefits, and low risk of 
hypoglycemia. However, the purpose of this case is to recognize when popular diets can 
complicate use of these medications. 
 
Case Presentation 
A 38-year-old male with past medical history of T2DM, tobacco use, and pulmonary 
embolism presented to the emergency department with crushing chest pain that radiated down 
his left arm, with intermittent chest pain the last several weeks. The only medications he took 
were metformin and canagliflozin, the latter of which he started less than a week prior. Social 
history revealed that the patient was on a ketogenic diet, restricting carbohydrate intake while 
increasing fat consumption. His vitals and physical exam were benign, with the exception that 
the chest pain was reproducible on palpation of the anterior chest wall. He had normal troponins 
and myocardial perfusion. His complete metabolic panel indicated a low sodium of 131 mmol/L, 
elevated serum glucose of 127 mg/dL, decreased bicarbonate of 12 mmol/L, serum anion gap of 
17, and was otherwise within normal limits. His lactic acid was normal. However, urinalysis 
indicated 3+ glucose, 2+ ketones, and 1+ protein. He had elevated beta-hydroxybutyrate at 9.3 
mmol/L (normal < 0.3) even though his serum glucose levels remained below 200 mg/dL for 
most of his two-day hospital course. Finally, an arterial blood gas of 7.21/25/112 indicated anion 
gap metabolic acidosis with appropriate respiratory compensation. His history and labs were 
suggestive of euglycemic diabetic ketoacidosis (DKA). He was successfully treated with an 
insulin drip coupled with D5, and later D10 drips and frequent potassium replacement that 
resolved his chest pain while decreasing his serum beta-hydroxybutyrate and serum anion gap. 
 
Conclusions 
This case suggests practitioners should be cautious in prescribing SGLT-2 inhibitors for type 
2 diabetics on the frequently encountered ketogenic diet. SGLT-2 inhibitors decrease 
reabsorption of glucose at the renal tubules while promoting fatty acid oxidation and ketone 
bodies formation as an alternative energy source. The ketogenic diet promotes ketosis without 
significant changes in blood pH, plasma bicarbonate, or blood glucose in comparison to DKA 
because of the intentional restriction of carbohydrate intake with increased consumption of 
dietary fats. It is recognized that the harmless ketosis caused by SGLT-2 inhibitors can become 
harmful DKA when coupled with factors like postoperative status or poor nutrition, especially 
given that this patient tolerated SGLT-2 inhibitors for six months without issue before starting 
the diet. Further research is needed on the topic, and in the interim mindfulness of euglycemic 
DKA is critical in this population.  
 Gender Disparities in Secondary Preventive Measures 
for Atherosclerotic Cardiovascular Disease in Kansas 
Roshni Jain, Tabitha Muutu, M.D., Paul Ndunda, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
In Kansas, cardiovascular disease (CVD) is the leading cause of death. Heart disease and 
stroke caused 6,988 deaths in 2015, making Kansas’ death rate from CVD the 23rd highest in the 
country. More than 47% of heart attack survivors and 30% of stroke survivors suffer recurrent 
events, which highlights the need for data on secondary preventive care. There is evidence from 
national data of gender disparities in CVD morbidity, mortality, and preventive medication use. 
However, data are lacking on the disparities in secondary prevention in Kansas. The objective of 
this study was to assess the gender differences in lifestyle secondary preventive measures in 
patients from Kansas with CVD. 
 
Methods 
This study is an analysis of the 2015 Behavioral Risk Factor Surveillance System (BRFSS), a 
chronic disease and behavioral risk factor survey conducted by the CDC. The sample included 
2,686 subjects from Kansas with a history of coronary heart disease and stroke. The demographic 
characteristics were analyzed using chi square and 2-sample t-test. The secondary preventive 
measures tested included: exercise, diet, smoking cessation attempt, alcohol intake, body mass 
index, and use of blood pressure medications in hypertensive patients. Gender disparities were 
analyzed using logistic regression analysis. Among the covariates tested age, race, education, and 
income showed significant effects on the model and were adjusted for in the outcomes.  
 
Results 
Women comprised 48.7% of the CVD cohort with no significant differences in race 
proportions between genders. The median ages of the study subjects were 68 and 72 years for 
men and women, respectively. Women were less likely to have ever smoked (47.5% vs 66.8% 
OR 0.44 (0.35, 0.55) p < 0.0001) and more likely to have made a smoking cessation attempt 
(70.7% vs 54.7% OR 2.35 (1.33, 4.15) p = 0.003). There was no difference in the odds of being 
current smokers (17.1% vs 17.8% OR 1.17 (0.96, 1.49) p = 0.213). Women were less likely to 
meet the AHA aerobic and muscle strengthening exercise guidelines (11.9% vs 17.4% OR 0.71 
(052, 0.95) p = 0.023), but they were more likely to eat ≥ 4 servings of vegetables per day (OR 
1.66 (1.06, 2.60) p = 0.026) and ≥ 4 servings of fruit per day (OR 1.83 (1.05, 3.17) p < 0.032). 
Women were more likely to have a BMI < 25 (1.79 (1.47, 2.18) p = 0.0001), and hypertensive 
women were more likely to be on antihypertensive medications (OR 1.636 (1.033, 2.591) p = 
0.036). There was no difference in heavy alcohol use (OR 0.813 (0.472, 1.399) p = 0.45). 
 
Conclusions 
Patients with CVD in Kansas do not meet AHA lifestyle modification recommendations, and 
there are significant gender disparities in adherence to the studied CVD secondary preventive 
measures. 
  
 Treatment of Refractory Acute Myeloid Leukemia with Isocitrate Dehydrogenase Inhibitor 
Aarati Keshary, M.D., Jeremy M. Deutsch, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Acute myeloid leukemia (AML) is a disorder of poorly differentiated myeloid precursors that 
accumulate in the bone marrow and interfere with the production of normal cells. The overall 
prognosis with a five year survival rate is 22%. This prognosis can be affected by the presence or 
absence of certain mutations. The Isocitrate Dehydrogenase (IDH) gene is involved in cellular 
metabolism and in epigenetic regulation in the Krebs cycle. Mutations in IDH1 or IDH2 are 
detected in approximately 20% of patients with AML after patients undergo additional 
genotyping. These mutations catalyze alpha-ketoglutarate leading to DNA hypermethylation, 
altered gene expression, and blocking of hematopoietic differentiation of myeloid progenitor 
cells due to overproduction of 2-hydroxyglutarate, an oncometabolite, promoting 
leukemogenesis. A drug has been developed for the treatment of IDH-2 and IDH-1 mutations 
and is undergoing clinical trials. We present a case of refractory AML with IDH-1 mutation that 
achieved remission with an IDH-2 mutation inhibitor, Enasidenib. 
 
Case Presentation 
A 53-year-old female with a history significant for hypothyroidism was seen for evaluation 
of pancytopenia. Bone marrow (BM) biopsy confirmed AML with more than 90% blast cells. 
She was admitted for initiation of induction chemotherapy with idarubicin and cytarabine. 
Following the first induction, a repeat BM biopsy showed refractory AML. She underwent a 
second induction with Mitoxantrone and VP16. Repeat BM biopsy showed hypocellular marrow 
with 18-20% residual AML. She developed a diffuse erythematous rash that was thought to be 
due to Cytarabine. Given that the patient failed two induction therapies, she was approved for 
Enasidenib. The rash continued to worsen with ulceration. Biopsy revealed septate fungal hyphae 
and blood culture was positive for Fusarium species. Infectious disease recommended treatment 
with ambisome, vancomycin, and meropenem. The patient achieved complete remission on 
Enasidenib as evidenced by repeat BM which showed less than 5% blast cells. She developed 
complications such as acute renal failure, elevated liver enzymes, and neutropenic fever which 
resolved. She was discharge on day 61 with three-month remission. 
  
Discussion 
AML with IDH1 and IDH2 mutations are rare with IDH1 mutation being rarer. However, 
prognosis based on mutation type in AML remains controversial. Many cases have been 
refractory to a traditional chemotherapy regimen. Enasidenib was developed specifically for the 
treatment of refractory and relapsing AML cases such as ours. It is a selective targeted inhibitor 
of the mutant IDH2 enzyme that is approved for the treatment of refractory or relapsing AML 
with IDH2 mutations. However, we present a case of AML with IDH1 mutation that showed 
complete remission on Enasidenib. Further investigation is needed to assess the efficacy of 
Enasidenib as part of a first line regimen for the treatment of AML with IDH mutations. 
  
 Maintaining a High Suspicion for Ehrlichiosis in the Heartland 
Mejalli Al-Kofahi, M.D., Usman Nazir, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Ehrlichiosis is a rare tick-borne illness with increasing incidence. In 2016, there were 1,377 
cases, 50% of which reported from four states that included Missouri. Clinical presentation is 
non-specific and difficult to distinguish from other etiologies. We present a case with concurrent 
enteropathogenic Escherichia coli (EPEC) infection confounding the clinical picture leading to 
further evaluation to diagnose Ehrlichiosis.  
  
Case Presentation 
A 43-year-old male with a past medical history of colon cancer and ulcerative colitis status 
post hemi-colectomy presented with a one-week history of myalgias, fevers, nausea, vomiting, 
confusion, watery diarrhea, and ten-pound weight loss after a recent diagnosis of EPEC. He had 
frequent tick bites removed regularly by his wife. He lived in a ranch close to Joplin, Missouri 
raising livestock. Pertinent positives on physical exam included tachycardia, hypotension, 
injected bilateral conjunctiva, and diaphoretic appearance with erythema over his abdomen. 
Laboratory work showed hemoglobin 12.3 g/dl, platelet count 114 K/UL, lactate dehydrogenase 
(LDH) 1084 U/L, haptoglobin 219 mg/dl, fibrinogen 146 mg/dl, creatinine 7.68 mg/dl, aspartate 
aminotransferase (AST) 329 U/L, alanine aminotransferase (ALT) 191 U/L, and alkaline 
phosphatase 168 U/L. Computer tomography (CT) of head, abdomen, and pelvis was positive for 
gallbladder wall thickening. 
The patient started on vancomycin, meropenem, and doxycycline, and aggressively 
resuscitated without requiring vasopressors. Peripheral smear showed one schistocyte per high 
power field, and ADAMTS13 was 58% (normal range > 70%). Acute hepatitis panel, fungitell, 
blood, and urine cultures, serum shiga toxin, urine eosinophilic stain, and serum antibodies 
against Leptospira, Brucella, and Babesia were all negative. Ehrlichia IgG titer was 1:256 with a 
reference range of < 1:64. Serum PCR of Anaplasma phagocytophilum, Ehrlichia chaffeensis, 
Ehrlichia ewingii/canis, and Ehrlicia muris like were all negative. Diagnosis of Ehrlichiosis was 
made and symptoms completely resolved within five days. He was discharged to complete a total 
of 14 days of doxycycline.  
 
Conclusions 
Missouri and Kansas are listed by the CDC as endemic areas for E. chaffeensis, which is one 
of the most common etiologies of Ehrlichiosis. Thus, internists in those states should keep 
Ehrlichiosis on the differential diagnoses with patients who have non-specific flu-like illnesses, 
and unexplained thrombocytopenia, leukopenia, elevated liver enzymes, and LDH, especially in 
patients who have history of tick bites. Our case was confounded by the recently diagnosed 
EPEC that could explain the severe diarrhea and AKI, but not the high-grade fevers and other lab 
abnormalities. Diagnosis of Ehrlichiosis should be based on clinical suspicion as the sensitivity 
of serum PCR rapidly declines with treatment. Antibody titer against E. Chaffeensis antigen 
could assist in the diagnosis if a four-fold increase is seen within the first week of symptoms, or 
four fold decrease is seen within two to four weeks after treatment. First line treatment is 
doxycycline that should be started prior to diagnostic confirmation.  
 A Rare Cause of Anemia:  
74-year-old Male with High-Grade Neuroendocrine Tumor of the Colon 
Nicole Balmaceda, Mohammad Telfah, M.D., Mazin Al-Kasspooles, M.D.,  
Hongyan Dai, M.D., Ph.D., Prakash Neupane, M.D., Joaquina Baranda, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Colorectal cancer is the third most common cause of malignancies in both men and women, 
with the overwhelming majority being adenocarcinoma. An exceptionally rare histology type of 
colon cancer is high-grade large cell neuroendocrine tumors. Highly aggressive, these rare 
malignancies present challenges in treatment.  
 
Case Presentation 
A 74-year-old male presented to his primary care physician with weight loss, poor appetite, 
fatigue, and diffuse abdominal pain in 2018. Review of systems was negative for nausea, 
vomiting, change in bowel movement, blood in the stools, shortness of breath, or flushing. Past 
medical history includes hypertension and chronic kidney disease. On examination, he was pale 
but had no organomegaly. His hemoglobin was 8 gm/dL and creatinine was elevated. Bone 
marrow biopsy and urine studies were consistent with monoclonal gammopathy of undetermined 
significance. Five months later, the patient underwent colonoscopy which showed a large mass 
within the proximal transverse colon at the hepatic flexure. Biopsy of the colonic mass showed 
poorly differentiated invasive adenocarcinoma. Because of renal insufficiency, a CT with 
contrast could not be performed. Therefore, PET/CT imaging was done which demonstrated a 
hypermetabolic colonic mass with a maximum SUV of 25.9, compatible with primary 
malignancy, hypermetabolic mesenteric lymphadenopathy consistent with nodal metastatic 
disease, and multiple hypermetabolic mediastinal, hilar, and periportal lymph nodes of 
indeterminate significance. The patient underwent laparoscopic extended right hemicolectomy. 
Intraoperatively, suspicious-appearing enlarged central lymph nodes were noted. Surgical 
pathology revealed high-grade large cell neuroendocrine tumor with proliferative index of over 
90%. He was initially staged as III T3N2aM0. Because of this unexpected pathology associated 
with rapid progression, a baseline PET/CT was done, and systemic therapy planned. There were 
lung lesions too small to characterize, but no definite evidence of metastatic disease in the chest. 
However, this showed abdominal lymphadenopathy consistent with metastatic disease. Liver 
function tests, serum CEA, and urine 5-HIAA/CP were within normal limits. Chromagranin A 
was elevated at 315. The patient was started on carboplatin and VP-16 three weeks post-
operatively with plans to complete four to six cycles of this regimen.  
 
Conclusions 
Neuroendocrine tumors account for only 0.4% of all colorectal neoplasms. Current literature 
on optimal treatment strategies for large cell neuroendocrine tumors of the colon is sparse. Given 
the histologic similarities, these colonic malignancies are managed with the same regimens used 
in small cell lung cancer. However, emerging data suggest that poorly differentiated 
neuroendocrine tumors are a distinct disease entity from small cell lung cancer. A more thorough 
investigation of large-cell neuroendocrine tumors of the colon is warranted. 
 
 
 Sudden Cardiac Arrest in Late Adolescent  
with WPW Associated to Anabolic-Androgenic Steroid Abuse 
Maher Bazzi, M.D., Bassem Chehab, M.D. 
KU School of Medicine-Wichita 
 
Introduction 
Anabolic-androgenic steroids (AAS) have been implicated in multiple metabolic and cardiac 
abnormalities that can lead to disastrous events even in young healthy individuals. Reported here 
is a case of a late adolescent recently diagnosed with Wolff-Parkinson-White (WPW) syndrome 
presenting with sudden cardiac arrest following ventricular fibrillation in the setting of AAS 
abuse. This case highlighted the metabolic and imaging findings that may have contributed to the 
near-fatal presentation. 
 
Case Presentation 
A 19-year-old previously healthy male with recent diagnosis of WPW presented to an outside 
ED following loss of consciousness and cardiac arrest witnessed by his girlfriend. She initiated 
CPR for 10 minutes prior to EMS arrival. In the ED, he was found to be in ventricular fibrillation 
and ACLS protocol was performed, receiving two doses of epinephrine and a single shock prior 
to return of spontaneous circulation, at which point hypothermia protocol was initiated. He was 
intubated and sedated in the ED, then transferred to ICU. ABGs on admission showed mixed 
metabolic and respiratory acidosis. He was found to be in shock, requiring initiation of 
norepinephrine and vasopressin. Echocardiogram showed severely hypokinetic left ventricle with 
ejection fraction of 20-25%. Left heart catherization was performed and showed a co-dominant 
system with no significant coronary disease. Ventriculography showed a 15-20% ejection 
fraction. An intra-aortic balloon pump (IABP) was placed due to cardiogenic shock to help with 
pressure support. His troponin on admission was 1.06 and peaked within hours at 13.15. On day 
two, pressors were discontinued. IABP was removed by day three and paralytics were stopped. 
The patient was extubated and started on NIPPV for fluid overload. On day four, chest x-ray 
showed worsening pulmonary congestion and was started on diuretics. On day five, he was 
switched to high-flow nasal cannula at 6L with good urine output. He was eating, awake, and 
comfortable; the patient’s only complaint was short term memory loss. On day six, a cardiologist 
performed an EP study and showed left lateral pathway which was ablated. Repeat 
echocardiography on day seven showed concentric thickening with remodeling and estimated 
ejection fraction of 40-45%. Due to improved function, ICD placement was not indicated. On 
day eight, the patient was discharged home on aspirin and metoprolol, without need for oxygen. 
 
Conclusions 
This case illustrates the harmful effects of AAS with metabolic and structural changes 
including dyslipidemia and hypertrophic cardiomyopathy, which increases the risk for fatal 
arrhythmias. Previous literature is scarce on connecting AAS to sudden cardiac arrest, mostly 
related to arrhythmias and rarely related to ischemic heart disease. Awareness for AAS abuse 
with its associated short- and long-term effects should always be discussed, not only with 
professional athletes and bodybuilders, but also with young individuals that use steroids for 
aesthetic purposes.  
 Diffuse Bone Pain after Lung Transplant:  
Cystic Fibrosis Arthropathy or Voriconazole Induced Periostitis Deformans 
Amna Batool, MBBS, Megan Krause, M.D. 
KU School of Medicine-Kansas City 
 
Introduction 
Voriconazole is a fluoride-containing anti-fungal medication commonly prescribed to organ 
transplant recipients. Periostitis deformans is one of its uncommon side effects characterized by 
diffuse bone pain, elevated alkaline phosphatase, dense, irregular, bulky periosteal new bone 
formation on radiographs/CT, and increased uptake on Tc-99m MDP bone scan. 
 
Case Presentation 
A 34-year-old Caucasian female with cystic fibrosis status post lung transplant presented for 
evaluation of joint pain. She had developed polyarticular pain along with stiffness and limitations 
in range of motion three months after the transplant. There was no associated history of morning 
stiffness. Prior to transplant, she had a diagnosis of cystic fibrosis arthropathy which had 
responded well to hydroxychloroquine which had been restarted without any improvement. 
Physical exam was remarkable for significantly limited range of motion of the neck and other 
joints due to pain without any synovitis. Of note, she was on voriconazole for heavy growth of 
trichosporon in sputum. Laboratory work showed alkaline phosphatase elevated at 161 U/L, 
ANA elevated to 1:320, however, other serologies were within normal limits. Creatine kinase 
was 35 U/L. White blood cell count was normal. Rheumatoid factor was negative. Joint survey 
did not demonstrate any erosions. There was evidence of cortical thickness of the left medial 
femur without any history of trauma to that area. Given lack of improvement of symptoms with 
hydroxychloroquine, normal serologies, lack of inflammatory symptoms, and findings on 
radiological imaging, voriconazole-related periostitis was suspected and this medication was 
discontinued. She reported improvement of symptoms soon after discontinuation of the 
medication. Her alkaline phosphatase levels also normalized after stopping the medication. 
 
Conclusions 
Voriconazole-induced periostitis is commonly seen in immunosuppressed post-transplant 
patients especially lung transplant patients on chronic voriconazole therapy. Most common side 
effects of voriconazole are rash and elevated transaminases. Voriconazole is like fluconazole, 
however, it contains a fluorinated pyrimidine which is thought to be the etiology of this 
condition. Fluoride stimulates bone formation by activating osteoblasts. It has been reported that 
patients on at least six months or longer of chronic voriconazole therapy have elevated fluoride 
levels. Patients commonly present with diffuse severe bone pain, universally elevated alkaline 
phosphatase levels and dense, irregular, bulky periosteal new bone formation on radiographs/CT. 
It is also associated with increased uptake on Tc-99m MDP bone scan. Other differentials of 
diffuse periostitis include hypertrophic osteoarthropathy, thyroid acropachy, and other 
medications (vitamin A, prostaglandin). Treatment consists of discontinuation which leads to 
prompt improvement of symptoms. It is an uncommon condition, however, a thorough history 
and physical exam is very helpful in including or excluding most of these diagnoses and 
expediting a timely referral. 
